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1.1. Yeast as a model organism: 
 
Saccharomyces cerevisiae has long served as an exceptional model organism 
for studies of genetics and cell biology. It has many of the desired traits of a 
model organism; in particular, many yeast genes possess orthologs in higher 
eukaryotes, including mammals (Botstein et al. 1997). Bakers’ yeast is readily 
available, and it is easy as well as economical to grow. In addition, it is easily 
maintained in the laboratory due to its small size, minimal nutritional 
requirements and non-pathogenic nature. It has a short life cycle of 90 minutes, 
speeding up experimental data collection. Of particular importance, it exists as 
both a stable haploid and diploid, facilitating genetic manipulation. The size of the 
haploid genome is 1.2 x 107 bp, consisting of sixteen chromosomes ranging in 
size from 230,000 bp to 2,352,000 bp (Suter et al., 2006). The yeast genome 
was the first eukaryotic genome to be successfully sequenced in 1996 (Goffeau 
et al., 1996), and its annotation, furthermore, developed a basic blueprint for 
gene-finding studies in related lower eukaryotes. The genome is relatively 
compact with approximately 6,400 genes comprising 70% of the total sequence. 
The sequence data and annotations are publicly available through the 
Saccharomyces Genome Database (SGD) at www.yeastgenome.org. 
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Since cell processes in yeast are typically conserved in higher eukaryotes 
(Melese and Hieter, 2002), numerous studies in yeast over the years have led to 
a wealth of information on basic cellular processes, such as cell cycle 
progression, DNA replication and repair, protein translation, and metabolism. 
Yeast is an increasingly popular model for pharmacological/drug discovery 
studies as well (Outeiro and Giorgini, 2006); since 40% of yeast proteins are 
similar in sequence to human proteins, orthologs of human disease related 
genes can be studied informatively in yeast. In addition, yeast is an excellent 
model for the study of pathogenic fungi (Truckses et al., 2004). Most genes in 
fungi such as the human fungal pathogen, Candida albicans, and the corn smut 
fungus, Ustilago maydis, have orthologs in the budding yeast, and a lot of 
knowledge has been gained by studying the functions of these genes in S. 
cerevisiae (Lengeler et al., 2000).  
 
1.2. Yeast genomics: 
 
The budding yeast has proven to be an equally strong model for the development 
of genomic and proteomic technologies. With its compact genome and simple 
genetics, S. cerevisiae has provided the test template for the development of 
many large-scale experimental approaches. Numerous genomic methodologies 
have been developed to identify functions for the roughly 6,000 genes in yeast 
(reviewed in Kumar and Snyder, 2001; Scherens and Goffeau, 2004) and the 
resulting data sets, while not quite accomplishing that goal, have contributed 
significantly to our knowledge base of eukaryotic biology — particularly since cell 
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processes in yeast are typically conserved in higher eukaryotes as mentioned 
earlier. Following are a few examples of various genomic approaches used by 
different groups: 
1.2.1. Transposon-based gene disruption:  
 
In the mid-90’s, Burns et al. (Burns et al., 1994) generated a collection of yeast 
gene disruption mutants by transposon mutagenesis, and in several subsequent 
studies, this approach was expanded (Ross-Macdonald et al., 1999; Kumar et 
al., 2000), and modified (Kumar et al., 2004) to ultimately generate a collection of 
transposon insertion mutants encompassing nearly 3,800 yeast genes.  This 
collection provided the first genome-scale reagent resource suitable for 
systematic phenotypic screens of genes contributing to cellular stress. 
 The transposon mutagenesis approach is conceptually straightforward.  
Transposons are mobile genetic elements that randomly integrate themselves 
into the genome (Craig, 1997).  Transposons are present in many organisms and 
have been used as tools in the laboratory for decades.  Each transposon used in 
the studies referenced above was derived from a bacterial transposon, either Tn3 
(Hoekstra et al., 1991) or Tn7 (Biery et al., 2000), and was modified to contain 
bacterial and yeast selectable markers, a lacZ reporter gene and a 3XHA 
(haemaglutinnin) epitope (Ross-Macdonald et al., 1997).  The lacZ reporter gene 
is terminated by a series of stop codons; so, insertion of the transposon into a 
coding sequence truncates the gene at the site of insertion, disrupting gene 
function in most cases.  A random insertion in-frame with the surrounding gene 
coding sequence also results in the production of a β-galactosidase (β-gal) fusion 
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protein, a useful indicator of gene expression.  The transposon also contains a 
lox site at both ends that leads to the reduction of the transposon to a 274-bp 
3xHA element upon expression of the Cre recombinase in yeast (Cre-lox 
recombination).  This results in the production of a full-length HA-epitope-tagged 
protein that can be used for protein localization studies and for studies of 
essential genes.  Thus, the modified transposon was designed to be 
multifunctional, generating a gene disruption, reporter fusion, and epitope-tagged 
allele through a single insertion. 
The transposon was used for large-scale mutagenesis in yeast as follows.  
Briefly, a yeast genomic DNA library was transposon-mutagenized in vitro 
(Kumar et al., 2004) or in vivo (Ross-Macdonald et al., 1999) in Escherichia coli; 
in either case, plasmids were isolated in 96-well format, digested to release a 
fragment of transposon-mutagenized yeast genomic DNA, and the DNA fragment 
was transformed into yeast. By homologous recombination, each fragment 
integrates at its corresponding genomic locus, replacing its genomic copy.  
Transformants were subsequently assayed for β-gal activity to identify insertions 
within protein-coding genes.  Productive transposon insertions producing β-gal 
were selected into a separate collection, and corresponding plasmids were 
sequenced to identify the exact site of transposon insertion in each mutant.  In 
total, this collection encompasses over 28,000 yeast mutants, containing 
insertions affecting approximately 3,800 genes.  This collection of yeast 
transposon insertion mutants has subsequently been utilized for many 
phenotypic screens (Kumar et al., 2004). For example, Jin et al. screened 3,627 
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transposon insertion alleles in a filamentous strain of yeast and identified 309 
genes that played a role in pseudohyphal growth, a developmental process in 
yeast induced by certain environmental stress conditions (Jin et al., 2008). 
1.2.2. Genome-wide gene deletions: 
 
With the fully sequenced yeast genome available as a resource for gene-finding, 
an international consortium of laboratories undertook an approach in the late 
1990s to systematically delete every annotated gene in the genome (Winzeler et 
al., 1999). In Saccharomyces cerevisiae, precise start-codon-to-stop-codon gene 
deletions can be achieved using polymerase-chain reaction (PCR)-mediated 
gene disruption (Baudin et al., 1993).  In 1999, Winzeler et al. used a high-
throughput-based modification of this approach to delete 2,026 yeast genes, 
creating heterozygous deletion mutants, as well as 1,620 homozygous and 
haploid deletion strains (Winzeler et al., 1999).  By this approach, a PCR-
amplified selectable marker (KanMX, conferring resistance to geneticin (Wach et 
al., 1994) flanked by two sequences corresponding to regions upstream and 
downstream of each gene was introduced into a yeast strain.  Due to the high 
rate of homologous recombination in yeast, the PCR fragment replaced the 
targeted gene, creating a deletion mutant.  To identify each deletion mutant, two 
‘molecular barcodes’, 20-base unique sequences, were introduced into the PCR 
fragment flanking the selectable marker (Shoemaker et al., 1996). 
This preliminary collection of yeast gene deletion mutants was used to 
assay for mutant phenotypes as follows (Giaever et al., 2002). A collection of 
deletion strains was pooled together under certain conditions, and the presence 
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of each strain in the pool was ascertained by PCR amplification of the barcodes 
and subsequent hybridization to a high-density array of the barcode 
complements.  The absence of hybridized spots on the array for a particular gene 
deletion indicated that that gene is essential for growth under the particular 
condition in which the strains were grown.  In this study, phenotypes of more 
than 500 deletions were assayed, and 40% of these mutants showed quantitative 
growth defects in either rich or minimal medium.  This method can be used on a 
large scale to simultaneously examine the sensitivity of all deletion strains under 
any growth condition.  In particular, this approach highlights the foresight of the 
consortium in including molecular barcodes within the individual deletion 
cassette. 
1.2.3. Synthetic genetic interactions: 
 
In the quest to expand our knowledge of genetic/regulatory networks in yeast, a 
new method was developed by Tong et al. enabling the analysis of synthetic 
genetic interactions on a large scale (Tong et al., 2001).  As the name suggests, 
synthetic interactions involve a pair of mutations that result in a phenotype not 
observed in either single mutant; for example, the deletion of two non-essential 
genes may result in cell death.  Such interactions can help uncover functions of 
redundant genes, as researchers may screen a specific mutant for second-site 
mutations that either suppress or enhance the original phenotype.  Specifically, 
the synthetic genetic array (SGA) method involved the systematic construction of 
double-mutants by crossing a query mutation to an array of ~4700 haploid 
deletion mutants.  Double-mutant progeny were subsequently scored for viability.  
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Any inviable progeny would indicate a synthetic lethal interaction between the 
two deleted genes, thus identifying functional relationships between genes. This 
method has been used successfully in a number of studies to identify genetic 
interactions and thus create genetic interaction networks in yeast (Davierwala et 
al., 2005; Boone et al., 2007).  
1.2.4. Genome-wide gene overexpression constructs: 
 
In complement to gene deletion-based approaches, gene overexpression 
screens are a classic and informative methodology by which gene function may 
be investigated. In this method, a yeast strain is transformed with a DNA library 
constructed on a high copy vector or under an inducible promoter such as GAL1, 
and the resulting transformants are plated and screened for a particular 
phenotype.  For example, Jin et al. screened 2,043 genes under the control of a 
galactose-inducible promoter in a filamentous yeast strain and identified 199 
filamentous growth genes (Jin et al., 2008). Overexpression screens have also 
been successfully used to identify yeast genes conferring cellular resistance to 
drug treatment as a method to find new drug targets (Launhardt et al., 1998; 
Luesch et al., 2005; Sopko et al., 2006). 
1.2.5. Microarray analysis: 
 
DNA microarray technology was reported by Schena and colleagues in 1995 as 
a novel approach by which gene expression may be characterized on a large 
scale (Schena et al., 1995).  By this methodology, cDNA products were amplified 
by PCR and were mechanically deposited on microscope slides; mRNA 
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extracted under desired growth conditions was fluorescently labeled and 
hybridized against the arrayed cDNA products.  Hybridization of labeled mRNA to 
spotted cDNA was detected by laser scanning, such that fluorescent signal at 
any cDNA spot indicated expression of that gene.  Without belaboring the 
obvious, variations of microarray approaches have been used in numerous 
studies since to measure gene expression in organisms with sequenced 
genomes.   
In yeast, microarray approaches have been used extensively to measure 
gene expression upon exposure of cells to different conditions and stresses 
(DeRisi et al., 1997; Lashkari et al., 1997).  For example, in a groundbreaking 
study, Gasch et al. (Gasch et al., 2000) used microarray technology to profile 
gene expression in yeast under a wide variety of cell stresses and environmental 
growth conditions, identifying an extensive transcriptional program underlying 
cellular stress responses. Another more recent example is a study by Ma et al., 
who performed a microarray analysis of differential gene expression during early 
pseudohyphal growth in a filamentous strain of budding yeast (Ma et al., 2007). 
This study identified a wide variety of genes and pathways differentially 
expressed during this process and, more importantly, revealed a new link 
between filamentous growth and autophagy, another cellular stress response. 
1.2.6. Genome-wide yeast two-hybrid studies: 
 
The yeast two-hybrid method was developed by Fields and Song in 1989 to 
identify protein-protein interactions in yeast (Fields and Song, 1989).  The classic 
two-hybrid method is conceptually simple; interaction between two target proteins 
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results in the reconstitution of a functionally active transcription factor and 
corresponding reporter gene expression.  Specifically, the two-hybrid approach 
utilizes the yeast GAL4 transcriptional activator, which consists of two separable 
domains, a DNA binding domain and a DNA activation domain.  Each of these 
domains is fused to one of two test proteins; interaction between the test proteins 
brings the Gal4p DNA-binding and activation domains into close proximity, 
thereby restoring Gal4p transcriptional activity and Gal4p-target gene expression.   
The two-hybrid approach has been used extensively and is very amenable 
to high throughput applications, as evidenced by two independent large-scale 
studies identifying protein-protein interactions across the S. cerevisiae proteome 
(Uetz et al., 2000; Ito et al., 2001). The first study by Uetz et al. identified 957 
protein-protein interactions involving 1,004 proteins, whereas the second study 
by Ito et al. identified 4,549 two-hybrid interactions among 3,278 proteins 
generating a network linking most of the yeast proteins across the proteome.  
 
1.3. Filamentous growth in yeast: 
 
In response to certain nutrient limiting conditions in the external environment, 
some strains of budding yeast (e.g., the Σ1278b strain) undergo a significant 
change in growth form, transitioning from single, oval shaped cells to chains of 
elongated cells (Gimeno et al. 1992; Madhani and Fink 1998). This filamentous 
growth form occurs both in haploid and diploid cells of this strain; however, 
nitrogen limitation triggers this growth form in diploids (Gimeno et al., 1992), 
whereas in haploid cells, carbon limitation is the trigger (Cullen and Sprague, 
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2000). Various developmental processes occur to effect this change, such as a 
delay in the G2-Mitotic transition phase of the cell cycle that leads to elongated 
cell morphology (Gimeno et al., 1994; Kron et al., 1994). In addition, the budding 
pattern changes from axial (in haploid cells) or bipolar (in diploid cells) to a 
unipolar pattern, where the daughter cell buds off the mother opposite the bud 
scar (Roberts and Fink, 1994; Cullen and Sprague, 2002). This leads to the 
formation of chains of cells, called pseudohyphae. Pseudohyphal filaments can 
be differentiated from the true hyphae of fungi because pseudohyphae exhibit 
distinct cell walls.  
Pseudohyphal cells spread out on the surface of solid growth substrate; in 
addition, pseudohyphae invade the solid media on which they grow (Madhani 
2000). This developmental process is believed to be a way for cells to forage for 
nutrients in times of scarcity. Other inducing signals that lead to 
pseudohyphal/filamentous growth are the presence of short chain alcohols, such 
as butanol or propanol; these alcohols mimic the metabolic by-products that 
would occur when amino acids are used as a nitrogen source during nitrogen 
deprivation (Lorenz et al., 2000). Though filamentous growth occurs in both 
haploid and diploid yeast cells, in haploids, filaments don’t extend on the surface 
as much as in diploids (Gancedo, 2001). Hence, filamentous growth in haploids 
is generally referred to as invasive growth, though for the purpose of this text, 
filamentous growth will be used throughout to describe both developmental 
programs.  
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Various aspects of filamentous growth in the budding yeast share 
similarity with the hyphal growth of fungi, including the important human fungal 
pathogens, Candida albicans and Cyptococcus neoformans (Gagiano et al., 
2002). The signaling pathways and their components leading to filamentous 
growth in S. cerevisiae are conserved in these fungi. Thus, an understanding of 
the signaling cascades and elements involved in filamentous growth in yeast will 
be useful in learning more about the mechanism of pathogenesis in these 
organisms. 
  
1.4. Regulatory pathways leading to filamentous growth: 
 
In yeast there are at least two known signaling pathways leading to filamentous 
growth – the Mitogen Activated Protein Kinase (MAPK) pathway and the cAMP-
dependent Protein Kinase A (PKA) pathway (Kron, 1997; Madhani and Fink, 
1998). Both these pathways are triggered by nitrogen or carbon limitation, and 
hence both signaling pathways lead to filamentous growth in haploids or diploids. 
1.4.1. The Filamentous MAPK Pathway: 
 
The general mechanism of the evolutionarily conserved MAPK pathway involves 
an extracellular signal that sets off a cascade of signaling events culminating in 
the transcription of appropriate genes to effect the correct cellular response 
(Elion, 2000; Qi and Elion, 2005). This cascade consists of a mitogen-activated 
protein kinase kinase kinase (MAPKKK) that transfers its phosphate to a 
mitogen-activated protein kinase kinase (MAPKK), which in turn activates a 
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mitogen-activated protein kinase (MAPK). MAPKs are activated by dual 
phosphorylation of conserved threonine and tyrosine residues. Upon activation 
by the cascade, MAPKs often relocate to the nucleus where they activate 
proteins such as transcription factors by covalently attaching a phosphate to side 
chains of Serine or Threonine within a consensus motif on the target protein. This 
leads to the expression of pathway specific genes, resulting in an appropriate 
response to the extracellular signal.  
In response to certain nutrient limiting conditions such as low nitrogen in 
the media, the GTP-binding protein Ras2p is activated which binds and activates 
the guanine nucleotide exchange factor Cdc42p. This in turn activates GTP-
Cdc24p which interacts with the p21-activated kinase (PAK), Ste20p. Ste20p in 
turn activates the MAPK cascade consisting of the MAPKKK Ste11p, the MAPKK 
Ste7p and the filamentous growth-specific MAPK, Kss1p (Liu et al., 1993). Kss1p 
in its unphosphorylated cellular form is bound to the filamentous growth-inhibitory 
proteins, Dig1p and Dig2p as well as the transcription factor, Ste12p (Madhani et 
al., 1997). When Kss1p is activated by phosphorylation from the MAPK cascade, 
it phosphorylates Ste12p, leading to dissociation of Dig1p and Dig2p. Ste12p 
when released binds to another filamentous growth-specific transcription factor, 
Tec1p and these two proteins as a complex bind to target genes containing a 
Filamentous and invasive Response Element (FRE) in their promoter region.  
As is common amongst various MAPK pathways in most eukaryotes, the 
yeast filamentous MAPK pathway also shares components with other yeast 
MAPK pathways, not only within the MAPK cascade, but also upstream and 
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downstream of the cascade (Liu et al., 1993; O’Rourke and Herskowitz, 1998). 
The budding yeast has five other MAP Kinases involved in different pathways – 
Fus3p the mating MAPK, Hog1p for osmosensing, Slt2p and Mlp1p for cell 
integrity maintenance and Smk1p, the sporulation-specific MAPK. However 
erroneous crosstalk is limited in the cell by various mechanisms (Schwartz and 
Madhani, 2004). For example, the mating pathway not only shares three cascade 
components with the filamentous growth pathway, but also the downstream 
transcription factor, Ste12p is a common target. To prevent activation of 
filamentous growth during induction by mating pheromones, the mating-specific 
MAPK, Fus3p induces degradation of the Tec1p transcription factor (Bao et al., 
2004; Brückner et al., 2004). Thus Tec1p is no longer available to bind with 
Ste12p at FREs and there is no activation of filamentous growth target genes. 
1.4.2. cAMP-dependent /PKA pathway: 
 
The cAMP/PKA pathway in yeast regulates diverse cell processes such as cell 
growth, sporulation, bud site selection, aging, autophagy and filamentous growth 
(Broach 1991; Sun et al., 1994; Madhani and Fink, 1998; Pan and Heitman, 
1999; Budovskaya et al. 2004). Like the filamentous growth MAPK pathway, it is 
also induced by nutrient limitation and involves activation of protein kinase A 
(PKA) upon increase in cellular levels of cyclic-AMP (Palecek et al., 2002). This 
occurs through two mechanisms – one involving the GTP-binding protein, Ras2p 
and the other involves a G-protein coupled receptor, Gpr1p (Jiang et al., 1998). 
Gpr1p is bound to a heterotrimeric G-protein α subunit Gpa2p that acts as a 
nutrient sensor. Upon nutrient limitation, Gpa2p stimulates production of cyclic-
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AMP by activating the adenylate cyclase gene, CYR1. Ras2p in its GTP-bound 
form also stimulates production of cAMP via Cyr1p. cAMP binds to PKA, a 
tetrameric protein consisting of two regulatory subunits encoded by BCY1 and 
two catalytic subunits encoded by TPK1, TPK2 and TPK3. Upon, cAMP-binding, 
PKA dissociates, releasing the catalytic subunits. The Tpk2p subunit binds to 
downstream target genes, such as Flo8p, a filamentous growth transcription 
factor, subsequently leading to activation of filamentous growth.  
 
1.5. Different approaches to studying filamentous growth in yeast: 
 
Filamentous growth in Saccharomyces cerevisiae has been studied for 
approximately 20 years. Different groups have undertaken various approaches to 
study this fascinating developmental process. Besides the studies of single 
genes or pathways that have helped identify a number of genes involved in 
filamentous growth, a slew of genomic and proteomic approaches have also 
been used. A few of the studies that aim to identify filamentous growth genes and 
their regulation are mentioned below. 
To identify genes involved in filamentous growth, Jin and colleagues 
screened 4,528 gene disruption and overexpression mutants in the haploid 
Σ1278b yeast strain, thereby identifying 487 filamentous growth genes.   Besides 
identifying the genes involved in filamentous growth, other approaches have 
been implemented to determine the regulatory mechanisms by which these 
genes are controlled. For example, a microarray analysis by Ma et al. was used 
to measure differential gene expression during filamentous growth, identifying a 
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wide variety of genes and pathways differentially expressed during early 
filamentous growth (Ma et al., 2007). To measure protein abundance during 
filamentous growth on a large scale, a mass spectrometry-based approach has 
been undertaken  (personal communication). The authors have found a number 
of genes in various cellular processes that show differential abundance during 
filamentous growth. 
In Chapter 2 of this text, I describe a study of filamentous growth genes 
regulated by localization.  Here, the entire set of 125 yeast protein kinases were 
tagged with the Venus variant of Yellow Fluorescent Protein (vYFP) at the C-
terminus and localized under conditions of vegetative as well as filamentous 
growth. Six proteins changed localization under filamentous growth conditions; in 
addition, a network of regulated protein kinase localization during filamentous 
growth was also revealed. 
 
1.6. Candida albicans, the human fungal pathogen: 
 
Candida albicans is the primary fungal pathogen of humans. It lives as a 
harmless commensal in the gastrointestinal and genitourinary tract as well as on 
the skin and mucus membranes. However, in favorable conditions, such as when 
the immune system is compromised due to immunosuppressive treatment in 
patients who have undergone organ or bone marrow transplants, or patients 
undergoing cancer chemotherapy, it can proliferate and disseminate in the body 
(Berman and Sudbery, 2002; Noble and Johnson, 2007). Once it reaches the 
bloodstream it can invade tissues, causing life-threatening candidial infections of 
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the bloodstream, liver, kidneys, spleen or central nervous system. In otherwise 
healthy individuals, extended antibiotic treatment that eliminates competing 
bacteria can cause local mucosal infections, such as oral thrush or vaginitis. In 
patients with HIV/AIDS severe oropharyngeal or oesophageal candidiasis are 
more common than invasive candidiasis. Due to various complications in 
individuals, invasive candidial infections lead to death in approximately 40% of 
patients (Wisplinghoff et al., 2004). Candida has become an increasingly 
important pathogen, being one of the main factors of nosocomial infections. 
Treatment of candidial infections typically involves use of an azole 
antifungal such as fluconazole or itraconazole but as the disease tends to recur, 
azole-resisistant Candida albicans tend to develop. Development of new anti-
fungal drugs is hence extremely important in order to treat candidiasis and 
prevent its recurrence in patients. 
 
1.7. Challenges to genetic studies in Candida albicans: 
 
There have been reports in the literature of isolating Candida albicans as early as 
1839; however, it is only since the 1990s that laboratories began studying this 
important human pathogen in earnest (Noble and Johnson, 2007). There are 
various aspects to Candida that hindered progress in understanding its biology. 
Besides the fact that Candida albicans is a human pathogen, and hence care 
must be taken when working with this organism, a host of other issues have 
made it challenging to conduct experiments. For one, as Candida does not exist 
as a stable haploid, genetics is all the more cumbersome. Though there has 
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been some evidence of a sexual cycle in some engineered laboratory strains, 
this is an incomplete cycle lacking meiosis, hence leading to a tetraploid 
organism after mating of the diploid cells (Noble and Johnson, 2007). To study 
recessive mutations, it is therefore necessary to mutate both copies of a gene to 
observe any effect.  
Exogenously supplied DNA tends to integrate in Candida by homologous 
recombination, as it also does in S.cerevisiae; however, there are often cases of 
genes integrating via non-homologous recombination as well, so caution must be 
exercised in interpreting results from transformation-based approaches (Pla et 
al., 1996). Transformation efficiencies are extremely low in Candida, and large 
quantities of transforming DNA are required to achieve reasonable results. There 
are no naturally occurring replicating plasmids such as the 2µ plasmid in budding 
yeast. Certain plasmids that have been engineered to contain autonomous 
replicating sequences (ARS) invariably integrate into the Candida genome 
(Berman and Sudbery, 2002). C.albicans also translates the CUG codon as 
Leucine instead of Serine (Santos et al., 1997); so, the use of heterologous 
markers and tags was previously restricted to those that lack this codon in their 
sequence. Finally, since Candida is naturally resistant to antibiotics like 
G418/kanamycin (Fonzi and Irwin, 1993), many drug-resistance genes cannot be 
used as selection markers. 
However, numerous studies over the past ten years have served to 
facilitate experimental analysis in Candida albicans. For one, transformation 
efficiencies have been improved by trial and error of different experimental 
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conditions (Walther and Wendland, 2003). New heterologous markers have been 
designed, such as NAT1 (Shen et al., 2005; Schaub et al., 2006) and new 
reference strains like leu2Δ/leu2Δ (Noble and Johnson, 2004) have been 
developed.  GFP and its variants have been redesigned with a modified CUG 
codon (Morschhauser et al., 1998). Thus, numerous advances by multiple 
laboratories across the world have finally made it possible to perform more 
sophisticated experiments in C.albicans.  
Genome sequencing of the heterozygous diploid Candida albicans began 
in 1996 by the Stanford Genome Technology Center (Jones et al., 2004). It was 
completed and annotated in 2004, with revisions made as recently as 2006 
(Nantel, 2006; van het Hoog et al., 2007). Candida has a haploid genome size of 
16Mb with approximately 6,500 ORFs. The sequence data and annotations are 
freely available through the Candida Genome Database (CGD) at 
www.candidagenome.org. Since the sequencing of the genome was completed, 
there have been numerous genomic studies as well as individual gene/pathway 
studies on different aspects of Candida albicans biology. 
 
1.8. Morphogenesis of Candida albicans: 
 
Candida is known to exist in multiple growth forms – yeast, pseudohyphae, 
hyphae and chlamydospores (Sudbery et al., 2004; Whiteway and Oberholzer, 
2004). It adopts these various forms in response to its environment. Unlike most 
other fungal pathogens, Candida is not found in nature but is isolated from 
clinical samples from individuals. The yeast and hyphal forms are both found in 
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clinical isolates.  Yeast form cells are oval cells that divide by budding like in 
S.cerevisiae. They are typically found at acidic pH of approximately 4, at high cell 
densities of greater than 106 cells, and at low growth temperatures of 30°C. 
Yeast cells form pseudohyphae at a slightly higher pH of 6 and 35°C 
temperature, in addition to other triggers such as low nitrogen and high 
phosphate.  
Pseudohyphae are similar in form to those in S.cerevisiae – they consist 
of chains of elongated cells with distinct cell walls, in contrast to hyphal cells that 
have no constriction at the mother-bud junction and have a parallel cell wall 
along their length. The width of pseudohyphal cells is also greater, with a 
minimum width of about 2.8 µm, whereas hyphal cells have a width of 
approximately 2µm (Sudbery et al., 2004). Hyphae are formed from yeast cells in 
response to many different conditions such as serum, N-acetylglucosamine, 
physiological temperature of 37°C and neutral pH, and microaerophillic 
conditions. In addition, macrophage engulfment and iron deprivation also trigger 
the yeast-hyphal transition. Chlamydospores are large cells with thick cell walls 
that are formed mainly from hyphae under nutrient-poor micoraerophillic 
conditions at low temperatures (Whiteway and Oberholzer, 2004). 
 
1.9. Regulatory pathways leading to hyphal development in Candida: 
 
The ability to switch between the yeast, pseudohyphal and hyphal forms is 
believed to be important for virulence. This was inferred from a study of Candida 
mutants that were unable to undergo a switch to the hyphal form – these mutants 
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were avirulent in a mouse model of pathogenesis (Lo et al., 1997). Also, mutants 
that can’t undergo hyphal growth have decreased virulence in various in vivo and 
ex vivo models of candidial infections (Zheng et al., 2004; Thewes et al., 2007). It 
has been suggested that yeast form cells play a role in dissemination while the 
hyphal form is important for invasion of host tissue (Gow, 2002). Thus the yeast- 
to-hyphal switch is an important factor to consider in understanding the 
pathogenesis of this organism.  
Studies of the yeast-to-hyphal transition have revealed the existence of 
multiple regulatory pathways that respond to various environmental triggers – 
some of them being the MAPK pathway (Kohler and Fink, 1996; Román et al., 
2007), the cAMP-dependent PKA pathway (Biswas et al., 2003) and the RAM 
pathway (Song et al., 2008). The MAPK and PKA pathways are amongst the 
better-characterized ones and are analogous to those found in the yeast-to-
pseudohyphal switch in Saccharomyces cerevisiae (Dhillon et al., 2003).  The 
RAM network regulates many cell processes in eukaryotes, including hyphal 
development in C.albicans (Nelson et al., 2003; Song et al., 2008). 
1.9.1. MAPK pathway:  
 
The MAPK pathway that regulates the yeast-hyphal transition in C.albicans is 
triggered by various environmental conditions acting through the GTP-binding 
single Ras protein homolog, Ras1p (Biswas et al., 2007). When Ras1p is 
activated, it binds and activates the guanine nucleotide exchange factor Cdc42p, 
in turn activating Cst20p, analogous to the PAK kinase, Ste20p in yeast. 
Additional proteins of the cascade include the MAPKK, Hst7p and the MAPK, 
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Cek1p, homologous to Kss1p. The transcription factors downstream of this 
cascade are Cph1p, the Ste12p yeast homolog, and Tec1p, homologous to 
S.cerevisiae Tec1p. 
1.9.2. cAMP-dependent PKA pathway: 
 
Like in the budding yeast, the cAMP/PKA pathway in C. albicans involves 
activation of protein kinase A (PKA) upon increase in cellular levels of cyclic-AMP 
(Biswas et al., 2003). Activation of this pathway occurs via the amino acid-
sensing G protein-coupled receptor system Gpr1p-Gpa2p. Ras1p in its GTP-
bound form also stimulates production of cAMP by activation of the adenylate 
cyclase gene, CDC35. PKA in C.albicans consists of a regulatory subunit, Bcy1p 
and two catalytic subunits, Tpk1p and Tpk2p.  When cAMP binds to PKA, the 
subunits dissociate, and the catalytic subunits phosphorylate and activate the 
downstream transcription factor, Efg1p, leading to cAMP-dependent 
morphogenesis.  
1.9.3. RAM network: 
 
The RAM (Regulation of Ace2 and Morphogenesis) network consists of six 
genes present in both C. albicans and S. cerevisiae – namely, CBK1, MOB2, 
KIC1, HYM1, TAO3 and SOG2 (Song et al., 2008). The RAM pathway regulates 
diverse cell processes in both eukaryotes, such as cell separation, daughter cell-
specific localization of the transcription factor Ace2p, cell wall integrity, and 
polarized growth (Jansen et al., 2006, Nelson et al., 2003). In addition, the RAM 
network is involved in hyphal development in C.albicans. In S.cerevisiae, Mob2p 
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binds Cbkp1 and is responsible for its activation and correct localization. The 
Kic1p kinase functions upstream of the Mob2p-Cbk1p complex, and Kic1p likely 
activates these proteins. Hym1p interacts with both Cbk1p and Kic1p and is 
responsible for localization of this complex. Cbk1p is a serine/threonine protein 
kinase in the Ndr/LATS family; it phosphorylates Ace2p, which regulates 
numerous targets contributing to wild-type cell polarity (Mazanka et al., 2008). 
The role of the RAM network proteins in hyphal development in Candida has 
been shown by a number of independent studies on Cbk1p (McNemar and 
Fonzi, 2002; Uhl et al., 2003) Mob2p (Song et al. 2008) and the Ace2p 
transcription factor (Kelly et al., 2004). 
 
1.10. Genomic studies of hyphal growth in Candida albicans: 
 
Various approaches have been undertaken over the years to understand 
the signaling pathways leading to hyphal development in Candida albicans. 
These studies have included both single gene / pathway studies as well as 
recent large-scale genomic studies (Bruno and Mitchell, 2004).  
1.10.1. Transposon mutagenesis:   
 
There have been two major large-scale transposon mutagenesis studies 
that have been used to investigate related aspects of hyphal development. The 
first study used transposon mutagenesis to identify genes involved in the yeast-
to-hyphal transition. Using in vitro transposition, Uhl and colleagues created and 
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screened 18,000 heterozygous mutant strains that led to the identification of 146 
genes involved in this process (Uhl et al., 2003). 
Another study by Davis et al. employed transposons to identify essential 
genes and regulators of alkaline pH-induced hyphal growth (Davis et al., 2002). 
Out of 253 transposon insertions, they identified three genes required for this 
process; the authors also identified 36 essential genes, twenty of which were 
homologs of essential genes in S.cerevisiae.  
1.10.2. Repressible gene collection: 
 
 In an attempt to identify essential genes in C.albicans, Roemer et al. 
created a collection of strains that contained 1152 genes whose expression was 
regulated by the antibiotic, tetracycline (Roemer et al., 2003). In this study, one 
allele was deleted from each strain, and the other was placed under control of a 
tetracycline-repressible promoter. Using this method, the authors identified 567 
essential C.albicans genes; importantly, only 61% of these genes had essential 
orthologs in S.cerevisiae. 
1.10.3. Microarray analysis: 
 
 The sequencing of the genome in the late 1990’s subsequently led to the 
production of microarrays contaning the ORFs of the entire genome of Candida 
albicans. This has resulted in numerous studies of the transcriptional response of 
genes under various conditions. For example, a microarray analysis of 6,333 
predicted ORFs in cells undergoing hyphal growth was performed which, 
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amongst other findings, led to the identification of several genes involved in 
virulence (Nantel et al., 2002). 
Another study by Mulhern and colleagues (Mulhern et al., 2006) used 
transcriptional profiling to identify genes regulated by the Ace2p transcription 
factor of the RAM network during hyphal development. They showed that ACE2 
regulates genes involved in cell separation and glycolysis, and is required for 
hyphal growth under hypoxic conditions. 
Thus, the development of new tools and techniques for genetic and 
genomic studies in C.albicans has resulted in a host of new information on the 
regulatory pathways leading to hyphal development, besides identifying various 
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2. Analysis of the Yeast Kinome Reveals a Network of Regulated Protein 





In eukaryotes, protein function is regulated through mechanisms controlling 
transcription, translation, post-translational modification, protein degradation, and 
subcellular localization.  In recent years, global and/or systematic studies have 
been employed to consider the majority of these regulatory mechanisms across a 
wide set of genes and proteins.  DNA microarray technologies (DeRisi, 1997; 
Gasch et al., 2001) and mass spectrometry-based approaches (Gygi et al., 1999; 
Tang et al., 2005; Roth et al., 2006) have cataloged genome-wide changes in 
transcriptional levels, protein abundance, and post-translational modifications; 
however, our understanding of regulated protein localization remains cursory, 
constructed piecemeal from individual reports of a given protein whose function 
is regulated by its localization.   
Protein localization has been investigated most intensely in S. cerevisiae 
(Kumar et al., 2002; Huh et al., 2003), and reports of regulated protein 
localization have surfaced frequently in yeast-based studies.  For example, a 
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number of yeast proteins, such as the G1 cyclins Cln2p and Cln3p, are regulated 
by differential compartmentalization during cell cycle progression  (Edgington and 
Futcher, 2001).  The transcription factor Pho4p, involved in phosphate 
metabolism, is predominantly cytoplasmic under conditions of phosphate 
sufficiency, but localizes to the nucleus during phosphate starvation (O'Neill et 
al., 1996).  Components of the yeast Slt2p mitogen-activated protein kinase 
(MAPK) cell wall integrity pathway localize at sites of polarized growth in 
response to mating factor (Mazzoni et al., 1993; Buehrer and Errede, 1997).  
Collectively, from these and other studies (Shimada et al., 2000), we infer that a 
sizable protein complement may be regulated by differential localization in yeast, 
with protein kinases constituting one group particularly subject to such regulation. 
 Protein kinases play a prominent role in many developmental processes, 
and filamentous differentiation in yeast provides a strong example.  In certain 
strains of yeast (e.g., Σ1278b), MAPK and cAMP-dependent protein kinase 
(PKA) pathways mediate a stress-induced transition to a multicellular, 
filamentous growth form (Gimeno and Fink, 1994; Kron, 1997; Cullen and 
Sprague, 2000; Erdman and Snyder, 2001).  Specifically, nitrogen stress or 
growth in the presence of short chain alcohols initiates a developmental program 
characterized by the formation of filamentous chains of cells, called 
pseudohyphae (Lorenz et al., 2000).  During filamentous growth, yeast cells 
delay in G2/M, exhibit an elongated morphology, display an altered budding 
pattern, remain physically attached after cytokinesis, and invade their growth 
substrate (Gimeno et al., 1992; Kron, 1997; Madhani and Fink, 1998).  These 
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morphological and genetic changes are brought about through signaling 
pathways encompassing the Kss1p MAPK cascade (Ste11p, Ste7p, and Kss1p) 
and PKA (Liu et al., 1993; Pan et al., 2000).  In yeast, PKA consists of the 
regulatory subunit Bcy1p and the catalytic subunit isoforms Tpk1p, Tpk2p, and 
Tpk3p (Robertson and Fink, 1998).  As yeast cells undergo filamentous growth, 
these kinase-based signaling modules function with additional genes and 
pathways governing cell polarity, bud site selection, and cell cycle progression 
(Chandarlapaty and Errede, 1998; Miled et al., 2001; Madhani et al., 1999).  
Extensive regulatory mechanisms are in place to coordinate signaling pathways 
during filamentous growth (Gimeno and Fink, 1994; Borneman et al., 2006), and 
the subcellular distribution of yeast kinases is likely controlled as part of this 
regulation.   
 To consider the degree to which protein localization is regulated during 
eukaryotic cell growth, and, specifically, the extent to which this contributes to the 
filamentous growth response, we screened all protein kinases in the budding 
yeast for differential localization during filamentous growth.  This analysis 
revealed six kinases localized evenly across the cell during vegetative growth but 
localized predominantly in the nucleus under conditions of filamentous growth.  
Through localization-based epistasis studies, we found that the kinases form part 
of an interdependent network of regulated protein localization — the first such 
network identified in any eukaryote.  Our results indicate a 
“regulatory/subordinate” relationship among kinases within this subnetwork; 
using deletion mutants and kinase-dead alleles, we show that kinase 
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translocation, in many cases, requires the presence/activity of another kinase.  In 
addition, this study implicates the functionally uncharacterized Ser/Thr kinase 
Ksp1p in filamentous growth, while highlighting, in broader terms, the need to 
consider similar regulatory mechanisms in other eukaryotes.   
 
2.2. Materials and Methods 
 
2.2.1. Yeast strains and growth conditions:  
 
The filamentous yeast strains Y825 and Y825/6 are derived from Σ1278b 
(Gimeno et al., 1992).  The genotype of haploid Y825 is MATa  ura3-52 leu2Δ0; 
the genotype of diploid Y825/6 is ura3-52/ura3-52 leu2Δ0/leu2Δ0.  The non-
filamentous strain Y2269 is of the S288c genetic background and is a derivative 
of strain BY4743 (Giaever et al., 1999).  Deletion mutants were constructed in 
strain Y825 using a one-step PCR-based gene disruption strategy (Baudin et al., 
1993) with the G418 resistance cassette from plasmid pFA6a-KanMX6 (Longtine 
et al., 1998).  The sks1-K39R kinase-dead allele was generated by site-directed 
mutagenesis using oligonucleotides described in Yang and Bisson (1996).  
Kinase-dead alleles were obtained or generated on low-copy plasmids, except 
the ksp1-K47D allele, which is carried on pYEPs29K47D, described in 
Fleischmann et al. (1996). 
Standard growth medium for microscopy was prepared using 0.17% Yeast 
Nitrogen Base (YNB) without amino acids and ammonia, 2% glucose and 5mM 
ammonium sulfate (Guthrie and Fink, 1991).  Haploid filamentous growth was 
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induced in this standard medium supplemented with 1% (vol/vol) butanol (Lorenz 
et al., 2000) or on SLAD plates (0.17% yeast nitrogen base without amino acids 
and ammonium sulfate, 2% glucose, 50µM ammonium sulfate, with essential 
amino acids) plus 1% (v/v) butanol (Lorenz et al., 2000; Gimeno et al., 1992).  
Diploid filamentous growth was induced in liquid low-nitrogen medium (0.17% 
YNB without amino acids and ammonia, 2% glucose and 50µM ammonium 
sulfate) (Gimeno et al., 1992).  Invasive growth was assayed on YPD medium or 
synthetic complete (SC) –Ura as indicated (Guthrie and Fink, 1991; Lorenz et al., 
2000). 
2.2.2. Construction of yeast kinase-fluorescent protein fusions:  
 
In this study, we constructed a Gateway-compatible (Invitrogen Corporation, CA) 
yeast vector for the recombination-based cloning of promoter-gene cassettes as 
carboxy-terminal fusions to fluorescent protein (Walhout et al., 2000).  This 
Gateway vector was constructed from the centromeric yeast shuttle vector 
YCp50 (Rose et al., 1987).  To construct pDEST-vYFP, the Venus variant of 
yellow fluorescent protein (vYFP) (Nagai et al., 2002) was amplified by PCR from 
pBS7 (Yeast Resource Center, University of Washington) for introduction into the 
SphI-SalI site of YCp50.  Subsequently, the YCp50 vector carrying vYFP was 
digested with SphI and made blunt with T4 DNA Polymerase (New England 
Biolabs, MA).  Gateway cassette A (Invitrogen Corporation, CA) was ligated with 
the blunt-ended vector, and EcoRI was used to identify the orientation of the 
cassette.   
 In total, we cloned 119 kinase genes into pDEST-vYFP.  Briefly, we 
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amplified by PCR each open reading frame along with 1 kb of upstream genomic 
DNA for introduction into pDEST-vYFP; PCR primers contained phage lambda 
att sites allowing for recombination with the att-containing destination vector 
according to protocols described in Gelperin et al. (2005).  Upon cloning, the 
PCR product creates a translational fusion between the 3’-end of the gene and 
vYFP, with a 10-codon linker encoding NPAFLYKVVI.  The six remaining yeast 
kinase genes (MEC1, HRK1, RIM15, TEL1, TOR1, and TOR2) proved difficult to 
clone and were instead chromosomally tagged at their 3-ends with vYFP in the 
filamentous strain Y825/6; the genes HRK1, RIM15, TEL1, and TOR1 were also 
chromosomally tagged in Y825 as well.  Integrated alleles were generated by 
standard protocols using the vYFP-KanMX6 cassette from pBS7 (Yeast 
Resource Center, University of Washington). 
2.2.3. Live cell microscopy:  
 
Cells were grown overnight, diluted to an OD600 of roughly 0.1 and grown in 
standard medium or inducing conditions as required.  Filamentous growth in 
haploid strains was induced by inoculating diluted cultures into standard growth 
medium supplemented with 1% butanol for 4 hours at 30°C.  Diploid filamentous 
strains were induced as follows: overnight cultures were centrifuged, washed and 
inoculated at an OD600 of 0.1 into low-nitrogen medium at 30°C for 4 hours before 
observation.  Osmotic stress and heat stress were induced by growing diluted 
overnight cultures in standard growth medium to mid-log phase, followed by 
either 20 minutes growth in medium containing 0.4M NaCl (Ferrigno et al., 1998) 
or by 20 minutes growth at 37°C (Ferrigno et al., 1998).  4,6-diamidino-2-
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phenylindole (DAPI) was added at a final concentration of 2µg/ml for 30 minutes 
to stain DNA, marking the nucleus and mitochondria. 
2.2.4. Phenotypic assays for filamentous growth defects:  
 
Colony morphology of deletion mutants was observed by streaking mid-log 
cultures grown in YPD onto SLAD plates supplemented with 1% (v/v) butanol 
(Lorenz et al., 2000) and incubating at 30°C for 10 days.  Invasive growth was 
determined by the standard plate-washing assay of Gimeno et al. (1992).  For 
this assay, mid-log phase cultures were spotted onto YPD plates and incubated 





2.3.1. Localization of yeast kinases during filamentous growth:  
 
The yeast proteome encompasses 125 protein kinases, defined from data sets 
deposited in the Saccharomyces Genome Database as of August 2006 
(www.yeastgenome.org).  For purposes of this analysis, we include the 
regulatory subunit of protein kinase A, Bcy1p.  The yeast kinase complement, or 
kinome, is listed in Supplementary Figure SF2-1 (appendix), along with relevant 
functions and protein localization data describing the subcellular distribution of 
each protein in non-filamentous lab strains (e.g., S288c).  To investigate the 
subcellular dynamics of these kinases during filamentous growth, we constructed 
a unique plasmid-based collection of kinase-fluorescent protein fusions.  This 
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plasmid-based approach is well suited for localization studies in non-standard 
genetic backgrounds, such as in the filamentous strain Σ1278b; the Σ1278b 
genetic background is preferred for studies of filamentous growth (Gimeno et al., 
1992), and existing reagents for protein localization studies are not available in 
this strain.  As part of this study, we designed a centromeric yeast shuttle vector, 
pDEST-vYFP, for the expression of cloned genes as chimeric proteins in which 
the Venus variant of yellow fluorescent protein (vYFP) is fused to the carboxy 
terminus of the target protein (Nagai et al., 2002).  The pDEST-vYFP vector 
carries phage lambda att sites for recombination-based cloning, accommodating 
gene coding sequences along with 1 kb of upstream promoter sequence.  By 
virtue of this vector, genes are expressed under control of their native promoters 
at nearly endogenous levels. 
In total, we cloned 119 kinase genes into pDEST-vYFP and subsequently 
introduced the kinase-vYFP fusion into the filamentous strain Σ1278b by the 
approach outlined in Figure 2-1.  For six kinases (MEC1, HRK1, RIM15, TEL1, 
TOR1, and TOR2), C-terminal fusions to vYFP were generated as integrated 
alleles in Σ1278b (described in Materials and Methods).  The kinase-vYFP 
chimeras were screened by fluorescence microscopy for differential localization 
under vegetative and filamentous growth conditions in both haploid and diploid 
strains of Σ1278b, since the filamentous growth response differs according to 
ploidy (Gancedo, 2001).  A full listing of protein kinase localizations under these 
conditions is presented in Supplementary Table ST2-1 (appendix). 
From this analysis, we found six kinases with altered subcellular 
39 
distribution under filamentous growth conditions (Figure 2-2).  The proteins 
Bcy1p, Fus3p, Ksp1p, Kss1p, Sks1p, and Tpk2p distributed evenly over the cell 
under conditions of vegetative growth but localized predominantly to the nucleus 
during filamentous growth.  In each case, this nuclear shift was striking, with 
approximately 80-95% of observed fluorescence concentrated within the nucleus.  
The differential localization of these kinases was evident in both haploid cells 
(shown in Figure 2-2) and diploid cells for Bcy1p, Fus3p, Kss1p, Sks1p, and 
Tpk2p; however, Ksp1p did not localize strongly to the nucleus during 
filamentous growth in diploid yeast. 
 As mentioned previously, Bcy1p, Tpk2p, and Kss1p are known 
components of filamentous growth PKA and MAPK cascades, respectively.  
Fus3p is the MAPK mediating the yeast mating response (Elion et al., 1993; Choi 
et al., 1999), and Sks1p is a serine/threonine kinase involved in the cellular 
response to glucose limitation (Vagnoli and Bisson, 1998).  The cellular function 
of Ksp1p is unknown, although its overexpression is known to suppress 
mutations in SRM1, a nucleotide exchange factor required for nucleocytoplasmic 
trafficking of macromolecules (Fleischmann et al., 1996). 
To determine if the observed localization shifts are specific to the yeast 
filamentous growth response, we further screened the six yeast kinases identified 
above for differential localization during osmotic stress (in 0.4 M NaCl) and heat 
stress in Σ1278b.  Bcy1p is known to localize differentially during heat stress 
(Griffioen et al., 2001); however, the other kinase-vYFP fusions were distributed 
evenly over the cytoplasm and nucleus under the conditions tested.  Thus, the 
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observed nuclear shifts do not represent general stress responses and are likely 
specific to conditions inducing filamentous growth. 
2.3.2. Phenotypic analysis of nuclear-localized kinases: 
 
 To clarify the potential roles of these six kinases in filamentous growth, we 
deleted each corresponding kinase gene in a haploid derivative of Σ1278b for 
phenotypic analysis of filamentation (Figure 2-3).  Deletion mutants were 
screened for colony and cell morphologies, and invasive growth was assayed by 
the standard plate-washing assay of Gimeno et al. (1992).  Filamentous growth 
phenotypes were consistent across all assays.  Hyperfilamentous growth was 
evidenced by extended peripheral filamentation, elongated cell morphology, and 
increased invasive growth relative to wild type; the converse phenotypes were 
present in mutants defective in filamentous growth.  In our assays, deletion of 
KSP1, KSS1, and TPK2 resulted in decreased filamentous growth, while the 
fus3∆ mutant was hyperfilamentous.  Deletion of BCY1 and SKS1 did not affect 
filamentous growth.  These phenotypic results are consistent with our 
understanding of filamentous growth functions associated with Bcy1p, Fus3p, 
Kss1p, and Tpk2p; however, Ksp1p had not been implicated previously in 
filamentous growth, and, in this context, the strong effect of Ksp1p on 
filamentous growth is particularly noteworthy. 
 The kinase shifts reported here were identified using proteins tagged at 
their carboxy termini with vYFP; however, carboxy-terminal protein modifications 
can, in some cases, disrupt function.  To consider the functionality of these 
kinase-vYFP chimeras, we assessed the ability of Fus3p-vYFP, Ksp1p-vYFP, 
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Kss1p-vYFP, and Tpk2p-vYFP to complement corresponding deletion mutants 
for filamentous growth phenotypes.  In each case, introduction of the kinase-
vYFP fusion restored wild-type filamentous growth.  The Bcy1p-vYFP chimera 
complemented the heat-sensitive phenotype of a bcy1∆ mutant, as assayed by 
the method described in Toda et al. (1987).  The functionality of Sks1p-vYFP was 
not considered, because its null phenotype is not easily assayed. 
2.3.3. Interdependent kinase translocation to the nucleus during 
filamentous growth: 
 
 The regulated localization of Bcy1p, Fus3p, Ksp1p, Kss1p, Sks1p, and Tpk2p 
during filamentous growth and the known interplay between kinases in signaling 
pathways led us to consider the possibility that the observed nuclear 
translocation of these kinases may be interdependent: the presence of one 
kinase may be required for the localization shift of another.  To address this 
explicitly, we systematically examined the subcellular localization of these six 
kinases in mutant backgrounds individually deleted for one of the five other 
kinases.  For example, the subcellular distribution of Bcy1p was examined under 
conditions of vegetative and filamentous growth in five haploid mutant 
backgrounds: fus3∆, ksp1∆, kss1∆, sks1∆ and tpk2∆.  The remaining five kinases 
were also examined accordingly, and the results from this study are presented in 
Figure 2-4. 
Interestingly, the nuclear shift observed for Bcy1p, Fus3p, Ksp1p, and 
Sks1p is dependent in each case upon the presence of at least one other kinase 
(Figure 2-4A and B).  Fus3p is distributed evenly across the cytoplasm and 
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nucleus under conditions inducing filamentous growth in a haploid strain deleted 
for KSP1.  The nuclear shift of Bcy1p requires the presence of Ksp1p, Kss1p, 
and Sks1p.  The predominantly nuclear localization of Ksp1p during filamentous 
growth is lost in strains deleted for BCY1, FUS3, SKS1, or TPK2.  The deletion of 
any kinase in this subset disrupts the nuclear shift of Sks1p under filamentous 
growth conditions.  In contrast, the localization of Kss1p and Tpk2p during 
filamentous growth is unaffected by the deletion of these kinases. 
 Many kinases in this localized subgrouping exhibit reciprocal relationships 
(Figure 2-4C).  The deletion of BCY1 affects the butanol-induced nuclear 
localization of Sks1p, and, reciprocally, deletion of SKS1 disrupts the nuclear 
shift of Bcy1p.  We observed similar effects for the kinase pairs Bcy1p-Ksp1p, 
Fus3p-Ksp1p, and Ksp1p-Sks1p.  Other kinase pairs, however, exhibit a 
unidirectional “regulatory/subordinate” relationship; for example, the presence of 
Fus3p is required for the nuclear shift of Sks1p, but SKS1 is not required for wild-
type localization of Fus3p under conditions of filamentous growth.  Similarly, 
Tpk2p contributes to the regulated localization of Ksp1p and Sks1p, but the 
reciprocal relationships are not evident.  Kss1p also contributes to the butanol-
induced nuclear shift of Bcy1p and Sks1p, although neither gene product affects 
the localization of Kss1p during filamentous growth. 
Taken collectively, the six kinases identified here form part of an 
interdependent network of regulated protein localization during filamentous 
growth (Figure 2-4D).  It is likely that additional proteins contribute to the 
regulated localization of these kinases; thus, the relationships indicated in Figure 
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2- 4 represent a portion of a potentially larger network.  In particular, our results 
highlight the key regulatory roles of Kss1p and Tpk2p; both proteins are required 
for the wild-type localization of members of this subnetwork (i.e., Bcy1p, Ksp1p, 
and Sks1p), but neither is affected by the presence of any other kinase tested 
here.  Ksp1p plays a central role in this network, affecting the localization of 
Bcy1p, Fus3p, and Sks1p, while itself requiring the presence of Bcy1p, Fus3p, 
Sks1p, and Tpk2p for wild-type localization under conditions of filamentous 
growth.  This is particularly interesting since Ksp1p had not been implicated 
previously in filamentous growth.  Downstream or subordinate roles are also 
evident within this subnetwork; in particular, all five other kinases are required for 
the nuclear localization of Sks1p, while its presence is only required for the wild-
type localization of Bcy1p and Ksp1p. 
This localization-based interdependence suggests regulatory relationships 
that may be investigated through traditional epistasis studies with double-deletion 
mutants.  For example, as outlined above, the localization of Ksp1p is affected 
upon deletion of BCY1, FUS3, SKS1, or TPK2; thus, we deleted each of these 
genes individually in a strain deleted for KSP1 to assess the impact of each 
mutation on the ksp1∆ filamentous growth phenotype.  The results from this 
analysis are shown in Supplementary Figure SF2-4 (appendix).  The ksp1∆fus3∆ 
mutant exhibited exaggerated filamentous growth, as assessed by examination 
of colony morphology, cell morphology, and invasive growth; this mimics the 
phenotype of fus3∆.  As expected, the ksp1∆tpk2∆ double mutant shows no 
filamentous growth; however, deletion of BCY1 and SKS1, respectively, restores 
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yeast filamentous growth in a ksp1∆ genetic background.  At minimum, this 
indicates a filamentous growth effect associated with sks1∆.  It is interesting that 
the ksp1∆ phenotype is masked by the phenotype associated with the other gene 
deletion in each double mutant.  From this, Ksp1p may serve an upstream role in 
filamentous growth pathways; however, it is very difficult to interpret these 
results, since we have no clear evidence that Ksp1p actually functions in a linear 
pathway with the PKA and/or MAPK modules. 
2.3.4. Kinase activity is required for the nuclear translocation of 
dependent proteins:  
 
Kinases serve both structural and catalytic functions in signaling pathways, 
phosphorylating target proteins but also, in many cases, acting as scaffolds 
facilitating protein-protein interactions (Madhani and Fink, 1997; Choi et al., 
1994).  To specifically determine the role of kinase phosphorylation in controlling 
subordinate protein translocation to the nucleus, we examined the subcellular 
distribution of Bcy1p, Fus3p, Ksp1p, Kss1p, Sks1p, and Tpk2p in kinase-dead 
mutants of Fus3p (fus3-K42R), Ksp1p (ksp1-K47D), Kss1p (kss1-K42R), Sks1p 
(sks1-K39R), and Tpk2p (tpk2-K99R) (Madhani et al., 1997; Zeitlinger et al., 
2003; Fleischmann et al., 1996; Yang and Bisson, 1996; Demlow and Fox, 
2003); Bcy1p was omitted from this study, because it does not possess a kinase 
domain.  As indicated in Supplementary Figure SF2-5 (appendix), each kinase-
dead mutant exhibits filamentous growth phenotypes mirroring those observed 
upon gene deletion. 
In this analysis, we individually introduced each kinase-dead allele into a 
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haploid Σ1278b strain deleted for the corresponding kinase gene and analyzed 
the subcellular localization of kinases dependent upon this protein for nuclear 
translocation during filamentous growth (Figure 2-5).  For example, the 
localization of Ksp1p and Sks1p was observed in a kinase-dead fus3-K42R 
mutant; the localization of Bcy1p, Fus3p, and Sks1p was assessed in the ksp1-
K47D mutant, and so on.  In each case, kinase activity was required for the 
observed localization shift.  As shown in Figure 2-5, Ksp1p-vYFP and Sks1p-
vYFP were evenly distributed across the nucleus and cytoplasm in a strain 
bearing the fus3-K42R allele under conditions of butanol-induced filamentous 
growth.  Similar results were observed over the full panel of mutants tested.  
Thus, the kinase activity of the identified proteins is required for the nuclear 
translocation of dependent kinases.  It should be noted that the required 
phosphorylation events may be indirect.  Also, observed protein localization was 
not affected in any kinase-dead mutant under conditions of vegetative growth 
(Supplementary Figure SF2-6) (appendix).  
2.3.5. The nuclear translocation of Ksp1p is required for wild-type 
filamentous growth: 
 
 As evidenced by its null phenotype, Ksp1p is required for butanol-induced 
filamentous growth in haploid yeast; however, the importance of its observed 
localization shift during filamentous growth cannot be explicitly determined from 
this finding.  To consider this point more directly, we generated a modified form 
of Ksp1p unable to translocate into the nucleus.  Specifically, we fused a nuclear 
export sequence (NES) to the 3´ end of KSP1-vYFP, as illustrated in Figure 2-
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6A.  The Ksp1p-vYFP-NES chimera was expressed from the native KSP1 
promoter on the low-copy destination vector described in Figure 2-1.  For this 
analysis, the NES was derived from the Rev protein of HIV-1 (Fritz et al., 1995), 
which has been used previously to direct nucleo-cytoplasmic trafficking in yeast 
(Murphy and Wente, 1996).  Attachment of this NES prevented the nuclear shift 
of Ksp1p under conditions of butanol-induced filamentous growth (Figure 2-6A).  
Phenotypic analysis of this NES-tagged mutant revealed significantly reduced 
filamentous growth as compared to a haploid ksp1∆ strain expressing the Ksp1p-
vYFP chimera: surface-spread filamentation and invasive growth was lost in the 
NES-tagged strain, and its cell morphology was rounded rather than elongated 
under conditions inducing filamentous growth (Figure 2-6B).  The ksp1-K47D 
kinase-dead mutant is also defective in filamentous growth (Supplementary 
Figure SF2-5) (appendix); therefore, the nuclear translocation of Ksp1p and its 
kinase activity are both required for wild-type filamentation, suggesting that 





From numerous individual examples, it is clear that the function of a protein can 
be controlled through mechanisms regulating its subcellular distribution; 
however, the extent to which this form of regulation occurs has not been 
investigated on a large scale.  Accordingly, we undertook the first systematic 
analysis of differential protein localization for any protein set in any eukaryote, 
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and using the yeast kinome as the subject, we identified an interdependent 
subnetwork of proteins whose intracellular localization is tightly regulated during 
filamentous growth.  This study, therefore, describes an underappreciated type of 
regulatory network, yields insight into the degree to which differential protein 
localization serves as a widespread regulatory mechanism, and also identifies 
the kinase Ksp1p as a new filamentous growth gene. 
 The plasmid collection described here constitutes a unique and versatile 
resource for the yeast scientific community, in complement to a very useful set of 
chromosomally integrated GFP-fusions presented in Huh et al. (2003).  
Obviously, however, our plasmid collection is not without its limitations; carboxy-
terminal fusions may perturb the functions of some proteins, and this is an 
important consideration in using these plasmids.  For example, carboxy-terminal 
tagging is typically problematic in analyzing isoprenylated gene products and 
geranylgeranylated proteins (Bhattacharya et al., 1995), as well as proteins 
modified with palmitoyl and farnesyl groups (Roth et al., 2006; Sun et al., 2004).  
While some proteins of the cell wall, endoplasmic reticulum, and peroxisomes 
may be adversely affected by carboxy-terminal modification, we do expect the 
majority of yeast proteins to function normally as C-terminal FP fusions (Pelham 
et al., 1988).  Plus, the alternative approach of amino-terminal tagging poses 
greater potential for protein mislocalization. 
By live-cell imaging of kinase-YFP chimeras, we found Bcy1p, Fus3p, 
Ksp1p, Kss1p, Sks1p, and Tpk2p differentially localized to the nucleus under 
filamentous growth conditions.  These kinases have been characterized to 
48 
varying degrees, and the pathway context of each is presented in Figure 2-7, 
along with a summary of our localization data.  In many cases, the observed 
localization shifts can be reconciled easily with corresponding protein functions.  
Specifically, PKA phosphorylates nuclear proteins, such as the filamentous 
growth transcription factor Flo8p (Rupp et al., 1999), under filamentous growth 
conditions; the nuclear shift of Bcy1p and Tpk2p likely enables PKA to selectively 
phosphorylate nuclear-localized targets during filamentation.  The filamentous 
growth MAPK Kss1p phosphorylates an incompletely defined set of nuclear 
proteins, including the transcriptional activator Ste12p.  Kss1p does not shift its 
localization in response to mating factor (Ma et al., 1995), and this filamentous 
growth-induced shift may constitute one mechanism ensuring Kss1p signaling 
specificity. 
In regards to this study, it should be noted that filamentous growth can be 
induced by conditions of nitrogen deprivation as well as by growth in the 
presence of short-chain alcohols, such as butanol.  Classically, pseudohyphal 
growth refers to a form of filamentous growth induced in diploid yeast by 
conditions of nitrogen deprivation on solid medium, wherein the yeast strain 
exhibits both surface-spread filamentation and invasive growth (Gimeno et al., 
1992; Gancedo, 2001).  Haploid strains of yeast undergo invasive growth on rich 
medium, but do not exhibit extensive surface-spread filamentation (Roberts and 
Fink, 1994).  Growth in butanol can be used to induce filamentation in haploid 
and diploid yeast, yielding morphological properties resembling pseudohyphal 
growth, even in liquid medium (Lorenz et al., 2000).  As compared to nitrogen 
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deprivation, butanol induction involves several underlying genetic differences; for 
example, Lorenz et al. (2000) report that numerous upstream nutrient-sensing 
genes required for classic pseudohyphal growth are not required for butanol-
induced filamentous growth.  We, however, identified at least two of these genes 
(GPA2 and GPR1) in a disruption screen for genes essential in butanol-induced 
haploid filamentous growth (Jin et al., 2008); thus, further analysis will be 
required to understand the genetic basis of these induction mechanisms.  To 
consider both induction schemes, in this study, we assayed kinase localizations 
in diploid yeast under conditions of nitrogen stress and in haploid yeast by growth 
in butanol.  Furthermore, we have endeavored to make clear the growth 
conditions used in each study throughout this text.   
As indicated from our data, Ksp1p represents an important new 
filamentous growth gene, since its deletion inhibits all characteristic filamentous 
growth landmarks in haploid yeast: cell elongation, surface-spread filamentation, 
and invasive growth.  Furthermore, the localization shift of Ksp1p is required for 
filamentous growth, as is its kinase activity.  This strongly suggests that Ksp1 
phosphorylates one or more nuclear proteins as an essential step in the yeast 
filamentous growth response.  At present, Ksp1p has no confirmed targets.  In 
vitro phosphorylation studies using protein microarrays identify 187 putative 
substrates for Ksp1p (Ptacek et al., 2005); however, none of these putative 
substrates belong to known filamentous growth pathways.  The nuclear shift of 
Ksp1p requires the presence of BCY1, TPK2, FUS3, and SKS1, and, at 
minimum, the kinase activity of Fus3p.  Ksp1p is not an established target of 
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these kinases, and the effect of Fus3p phosphorylation may be indirect.  
Interestingly, Ksp1p is a target for Hsf1p, Pho85p, and Pcl1p — hence its 
predicted involvement in the cell cycle and in the yeast general stress response 
(Hashikawa et al., 2006; Dephoure et al., 2005).  Since filamentous growth is 
coordinated with the cell cycle and general stress response machinery, Ksp1p 
may play an important role in the signaling link between these processes. 
The nuclear shifts of Fus3p and Sks1p are surprising.  Fus3p is 
phosphorylated by Ste7p and translocates to the nucleus in response to mating 
pheromone, where it phosphorylates Ste12p and the filamentous growth 
transcription factor Tec1p.  In the latter case, phosphorylation of Tec1p targets it 
for degradation, thereby inhibiting the filamentous growth pathway during mating 
(Bao et al., 2004; Elion et al., 1993; Choi et al., 1999).  During filamentous 
growth, the function of Fus3p in the nucleus is unclear, since it presumably 
cannot phosphorylate Tec1p under these conditions.  Fus3p may still be 
phosphorylated by Ste7p and may still phosphorylate Ste12p during filamentous 
growth.  Fus3p kinase activity is required for the nuclear translocation of Ksp1p 
and Sks1p during filamentation, suggesting that it possesses previously 
unappreciated roles in the yeast filamentous growth response.  The role of Sks1p 
in filamentous growth is also unclear, as its known functions are apparently 
distinct from those mediating filamentous growth, and its deletion does not affect 
filamentation.  In this context, kinase deletion phenotypes must be interpreted 
with caution, since kinases are known to engage in significant cross talk and 
compensatory activity (Madhani and Fink, 1997; McClean et al., 2007).  Thus, 
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the phenotype of a deleted kinase may be masked by activity from another 
kinase not normally functioning in a given process.    
 The observed localization shifts raise an interesting question regarding the 
mechanism by which these kinases translocate into the nucleus.  Little has been 
reported describing nuclear localization signals (NLSs) in these proteins, and 
sequence analysis by the program PSORTII (Nakai and Horton, 1999) suggests 
the presence of a putative NLS in only Ksp1p.  Thus, the remaining kinases are 
likely ferried into the nucleus through interaction with another protein.  For 
example, under conditions of temperature stress in S288c, Bcy1p translocates 
from the nucleus to the cytoplasm through an interaction with the protein Zds1p 
(Griffioen et al., 2001).  Similar interactions with other proteins may allow for the 
filamentous growth-induced translocation of the kinase subset reported here, 
although no obvious candidates are evident from interaction data sets. 
It is tempting to extrapolate our findings over the yeast proteome as a 
whole; however, we expect that the kinome is particularly subject to this form of 
regulatory control and that the overall percentage of yeast proteins regulated by 
differential localization will be less than the 5% rate (6 of 125) observed here.  
We do expect the transcription factor complement in yeast to be similarly 
regulated by subcellular localization to a high degree, and, in complement to this 
study, it would be interesting to screen the full set of yeast transcription factors 
for differential localization during filamentous growth. 
Collectively, this study presents the first large-scale analysis of differential 
protein localization in any eukaryote, and the kinase network identified here 
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defines a previously overlooked mechanism of regulatory control during yeast 
cell growth and development.  Conceptually, regulated protein localization 
provides a level of specificity to otherwise promiscuous kinase activities, and the 
network-based structure of this regulated localization confers greater specificity 
still.  The implications of these findings extend beyond our understanding of 
yeast cell biology.  Similar mechanisms are assuredly at play in higher 
eukaryotes as well, and subsequent investigations in higher organisms will clarify 
the degree to which these localization-based regulatory networks are 
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Figure 2-1 Schematic overview of the construction and subsequent 
screening of carboxy-terminal YFP fusions. Primers for PCR amplification 
were designed with 5’-att sites such that resulting PCR products could be cloned 
into the pDEST-vYFP vector by phage lambda-based recombination.  The 
resulting gene fusion carries a 10 codon linker between the target open reading 
frame and YFP.  Subsequent screening steps are as indicated, with a 
diagrammatic representation of a protein differentially localized to the nucleus 






Figure 2-2 Differential localization of the protein kinases Bcy1p, Fus3p, 
Ksp1p, Kss1p, Sks1p, and Tpk2p.  Kinase-vYFP fusions were visualized by 
fluorescence microscopy (left image) under vegetative growth conditions and 
during filamentous growth.  Yeast cells were stained with the DNA-binding dye 
4’,6-diamidino-2-phenylindole (DAPI; center image) to visualize the nucleus and 
mitochondria.  The yeast cell shape and vacuoles were imaged by differential 
interference contrast (DIC) microscopy (right image). 
 

















Figure 2-3 Phenotypic analysis of kinase deletion mutants in the 
filamentous Σ1278b genetic background.  Each haploid deletion mutant was 
assayed for: (A) surface-spread filamentation; (B) cell morphology; and (C) 
invasive growth.  Surface-spread filamentation was assayed on SLAD medium 
(Materials and Methods) supplemented with 1% butanol.  Cells from these 
colonies were inoculated into a small volume of water for differential interference 
contrast (DIC) microscopy.  Invasive growth was assayed on YPD medium as 
described in Materials and Methods.  The Σ1278b background strain Y825 
served as a wild-type control for these filamentous growth assays. 
 
 





Figure 2-4 Interdependent localization of yeast kinases during filamentous 
growth.  (A) Each kinase-vYFP fusion was visualized by fluorescence 
microscopy under filamentous growth conditions in a haploid strain of Σ1278b 
deleted for the indicated kinase.  DAPI-stained and DIC images are provided.  
Images of the kinase-vYFP fusions under vegetative growth conditions are 
presented in Supplementary Figure SF2-2 (appendix).  The mixed distribution of 
these kinases over the cytoplasm and nucleus signifies a loss of nuclear 
localization under filamentous growth conditions upon deletion of the indicated 
kinase gene.  Only kinases exhibiting a loss of nuclear localization are shown 
here.  (B) Matrix of kinase localizations in gene deletion backgrounds under 
conditions of filamentous growth.  The results corresponding to the images 
shown in part A are boxed in red.  Images of nuclear-localized kinase-vYFP 
fusions unaffected by the indicated gene deletions are presented in 
Supplementary Figure SF2-3 (appendix).  (C) Localization-based regulatory 
relationships among yeast kinases.  Each forward pointed arrow indicates that 
the given kinase is required for the wild-type localization of the subordinate 
kinase; for example, Fus3p is required for the wild-type nuclear localization of 
Sks1p during filamentous growth.  Reciprocal relationships between kinases are 
indicated by the circular arrows in the left column.  (D) The network of regulated 
protein localization between Bcy1p, Fus3p, Ksp1p, Kss1p, Sks1p, and Tpk2p is 
illustrated here; arrows are drawn as described for part C.  Double-sided arrows 
indicate that the localization of the given kinase pair is reciprocally affected under 
filamentous growth conditions. 
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Figure 2-5 The observed nuclear translocations are dependent upon the 
kinase activity of Fus3p, Ksp1p, Kss1p, Sks1p, and Tpk2p, respectively.  
Each indicated kinase-vYFP fusion was imaged in a strain carrying the kinase-
dead allele listed to the left.  For example, the subcellular distribution of Ksp1p 
and Sks1p is shown in a haploid fus3D strain carrying the fus3-K42R kinase-
dead allele on a low-copy plasmid.  DAPI-stained and DIC images are as 
described previously.  Note the mixed distribution of each kinase over the 
cytoplasm and nucleus upon loss of the indicated kinase activity.  Images of 
these kinases in the kinase-dead background strains under vegetative growth 







Figure 2-6 Tagging Ksp1p with a nuclear export sequence (NES) abolishes 
filamentous growth.  (A) Schematic diagram of the NES-tagged form of Ksp1p, 
where the NES (encoding LQLPPLERLTLD) is fused at the carboxy terminus of 
the Ksp1p-vYFP chimera.  As visualized by fluorescence microscopy, addition of 
the NES prevents the butanol-induced nuclear translocation of Ksp1p. DIC and 
vYFP images are shown.  Scale bar, 3 mm. (B) Phenotypic analysis of NES-
tagged Ksp1p.  For comparison, we have included a haploid ksp1D strain 
carrying a centromeric plasmid with the KSP1-vYFP fusion under transcriptional 
control of the native KSP1 promoter; this strain exhibits wild type filamentous 
growth properties.  Addition of the NES results in decreased filamentous growth, 
evidenced in a loss of surface-spread filamentation, rounded cell morphology, 
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Figure 2-7 Subcellular localization of the yeast kinome during filamentous 
growth. This diagram summarizes the localization of 125 protein kinases, 
constituting the yeast kinome, under conditions of filamentous growth.  In total, 
119 kinases do not shift localization during the transition to filamentous growth, 
and the localization of these kinases is tallied in the upper left.  For simplicity, 
Yck3p, which localizes to the vacuole, is included in the cytoplasmic 
compartment.  The six kinases that shift localization between vegetative and 
filamentous growth conditions are boxed in red, and the pathway context of each 
kinase is shown.  Flo8p and Ste12p are included as representative targets of 
Tpk2p and Kss1p, respectively.  Speculative and unknown interactions are 







2.5 Appendix  
Supplementary Figures and Tables 
Figure SF2-1 The yeast kinase complement, or kinome, is indicated, along 
with Gene Ontology terms describing the subcellular compartment to which 
each kinase has been localized in non-filamentous strains of yeast. 
Functions related to filamentous growth, mating, and cell cycle progression are 
color-coded alongside each kinase. 
 





Figure SF-2-2 Subcellular distribution of kinase-vYFP chimeras in the 
indicated kinase deletion mutants under vegetative growth conditions. 
Yellow fluorescence and DIC images are presented. Scale bar, 3µm. 
 





Figure SF-2-3 Nuclear-localized kinase-vYFP chimeras in the indicated 
deletion mutants. The images presented here identify nuclear shifts unaffected 
by the respective gene deletions. Yellow fluorescence and DIC images are 
presented. Scale bar, 3µm. 





Figure SF-2-4 Filamentous growth phenotypes of the indicated double 
deletion mutants. Colony morphology was assessed on synthetic complete (SC) 
medium and on SLAD plates supplemented with 1% butanol. Cells from these 
colonies were scraped into water for differential interference contrast microscopy. 
Invasive growth was assayed on YPD medium; plates were washed after 5 days 
growth. 
                     











Figure SF-2-5 Filamentous growth phenotypes of kinase-dead mutants. 
Colony morphology was determined on SC medium (normal nitrogen levels) and 
on SLAD medium supplemented with 1% butanol. Cells were scraped from 
colonies for DIC microscopy. Invasive growth was assayed on SC-Ura medium; 
plates were washed after growth for 5 days. 
 









Figure SF-2-6 Subcellular distribution of kinase-vYFP chimeras in haploid 
yeast strains carrying the indicated kinase-dead alleles under vegetative 
growth conditions. Yellow fluorescence and DIC images are presented. Scale 
bar, 3µm.  
 




Table ST-2-1 Kinase localization in haploid filamentous yeast (Y825). 
      
Kinase Vegetative Growth Filamentous Growth                
(1% Butanol) 
AKL1 Cytoplasm Cytoplasm 
ATG1 Cytoplasm Cytoplasm 
ARK1 Punctate Punctate 
BCK1 Cytoplasm Cytoplasm 
BCY1  Cytoplasm Nucleus 
BUB1  Cytoplasm, Nucleus Cytoplasm, Nucleus 
BUD32 Cytoplasm, Nucleus Cytoplasm, Nucleus 
CAK1 Cytoplasm (faint) Cytoplasm (faint) 
CBK1 Cytoplasm Cytoplasm 
CDC15 Cytoplasm Cytoplasm 
CDC28 Cytoplasm Cytoplasm 
CDC5 Cytoplasm (faint) Cytoplasm (faint) 
CDC7 Cytoplasm, Nucleus Cytoplasm, Nucleus 
CHK1 Cytoplasm Cytoplasm 
CKA1 Cytoplasm, Nucleus Cytoplasm, Nucleus 
CKA2 Cytoplasm Cytoplasm 
CLA4 Cytoplasm Cytoplasm 
CMK1 Cytoplasm Cytoplasm 
CMK2 Cytoplasm Cytoplasm 
CTK1 Cytoplasm, Nucleus Cytoplasm, Nucleus 
CTK2  Nucleus Nucleus 
CTK3  Nucleus Nucleus 
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Kinase Vegetative Growth Filamentous Growth                (1% Butanol) 
DBF2  Cytoplasm Cytoplasm 
DBF20 Cytoplasm Cytoplasm 
DBF4 Cytoplasm, Nucleus Cytoplasm, Nucleus 
DUN1 Cytoplasm (faint) Cytoplasm (faint) 
ELM1 Cytoplasm (faint), Bud neck Cytoplasm (faint), Bud neck 
FMP48  Mitochondrion, Cytoplasm (faint) 
Mitochondrion, Cytoplasm 
(faint) 
FUS3 Cytoplasm Nucleus 
GCN2 Cytoplasm Cytoplasm 
GIN4 Cytoplasm Cytoplasm 
HAL5 Cytoplasm (faint) Cytoplasm (faint) 
HOG1  Cytoplasm Cytoplasm 
HRK1  Cytoplasm Cytoplasm 
HRR25 Cytoplasm Cytoplasm 
HSL1  Bud neck Bud neck 
IME2 Cytoplasm (faint) Cytoplasm (faint) 
IPL1 Cytoplasm (faint) Cytoplasm (faint) 
IRE1  Cytoplasm (faint) Cytoplasm (faint) 
ISR1 Cytoplasm Cytoplasm 
KCC4 Bud, Cytoplasm Bud, Cytoplasm 
KIC1  Cytoplasm Cytoplasm 
KIN1 Cytoplasm Cytoplasm 
KIN2  Cytoplasm (faint) Cytoplasm (faint) 
KIN28 Nucleus Nucleus 
KIN3 Cytoplasm Cytoplasm 
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Kinase Vegetative Growth Filamentous Growth                (1% Butanol) 
KIN4 Cytoplasm Cytoplasm 
KIN82 Cytoplasm Cytoplasm 
KKQ8 Cytoplasm Cytoplasm 
KNS1 Cytoplasm (faint) Cytoplasm (faint) 
KSP1  Cytoplasm Cytoplasm 
KSS1 Cytoplasm Cytoplasm 
MCK1 Cytoplasm, Nucleus Cytoplasm, Nucleus 
MEC1 Cytoplasm Cytoplasm 
MEK1 Cytoplasm (faint) Cytoplasm (faint) 
MKK1 Cytoplasm Cytoplasm 
MKK2 Cytoplasm Cytoplasm 
MLP1 Cytoplasm (faint) Cytoplasm (faint) 
MPS1 Cytoplasm Cytoplasm 
MRK1 Cytoplasm (faint) Cytoplasm (faint) 
NPR1  Cytoplasm Cytoplasm 
PAK1 Cytoplasm Cytoplasm 
PBS2 Cytoplasm Cytoplasm 
PHO85 Cytoplasm Cytoplasm 
PKC1 Cytoplasm Cytoplasm 
PKH1 Cytoplasm Cytoplasm 
PKH2  Cytoplasm Cytoplasm 
PKH3 Cytoplasm (faint) Cytoplasm (faint) 
PRR1 Cytoplasm Cytoplasm 
PRR2 Cytoplasm Cytoplasm 
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Kinase Vegetative Growth Filamentous Growth                (1% Butanol) 
PSK1 Cytoplasm Cytoplasm 
PSK2  Cytoplasm Cytoplasm 
PTK1 Cytoplasm (faint) Cytoplasm (faint) 
PTK2 Cytoplasm Cytoplasm 
RAD53 Nucleus Nucleus 
RCK1 Cytoplasm Cytoplasm 
RCK2  Cytoplasm Cytoplasm 
RIM11 Cytoplasm Cytoplasm 
RIM15  Cytoplasm Cytoplasm 
RIO1 Cytoplasm Cytoplasm 
RIO2 Cytoplasm Cytoplasm 
SAT4 Cytoplasm Cytoplasm 
SCH9 Cytoplasm Cytoplasm 
SGV1 Cytoplasm, Nucleus Cytoplasm, Nucleus 
SKM1 Cytoplasm (faint) Cytoplasm (faint) 
SKS1 Cytoplasm Nucleus 
SKY1 Cytoplasm Cytoplasm 
SLN1 Cytoplasm Cytoplasm 
SLT2 Cytoplasm, Nucleus Cytoplasm, Nucleus 
SMK1 Cytoplasm (faint) Cytoplasm (faint) 
SNF1 Cytoplasm, Nucleus Cytoplasm, Nucleus 
SPS1 Cytoplasm (faint) Cytoplasm (faint) 
SSK2  Cytoplasm Cytoplasm 
SSK22 Cytoplasm (faint) Cytoplasm (faint) 
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Kinase Vegetative Growth Filamentous Growth                (1% Butanol) 
SSN3  Cytoplasm, Nucleus Cytoplasm, Nucleus 
STE11 Cytoplasm Cytoplasm 
STE20  Cytoplasm Cytoplasm 
STE7 Cytoplasm Cytoplasm 
SWE1 Cytoplasm Cytoplasm 
TEL1 Mitochondrion, Cytoplasm  Mitochondrion, Cytoplasm  
TOR1 Cytoplasm (faint) Cytoplasm (faint) 
TOR2 Cytoplasm (faint) Cytoplasm (faint) 
TOS3 Cytoplasm Cytoplasm 
TPK1 Cytoplasm Cytoplasm 
TPK2 Cytoplasm Cytoplasm 
TPK3 Cytoplasm, Nucleus Cytoplasm, Nucleus 
VHS1 Cytoplasm Cytoplasm 
VPS15 Cytoplasm (faint) Cytoplasm (faint) 
VPS34 Cytoplasm (faint) Cytoplasm (faint) 
YAK1 Cytoplasm, Nucleus Cytoplasm, Nucleus 
YBR028C Cytoplasm Cytoplasm 
YCK1 Cytoplasm, Nucleus Cytoplasm, Nucleus 
YCK2 Cytoplasm Cytoplasm 
YCK3 Vacuole Vacuole 
YDL025C Cytoplasm (faint) Cytoplasm (faint) 
YGK3 Cytoplasm (faint) Cytoplasm (faint) 
YGL059W Cytoplasm (faint) Cytoplasm (faint) 
YKL171W Cytoplasm, Nucleus Cytoplasm, Nucleus 
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Kinase Vegetative Growth Filamentous Growth                
(1% Butanol) 
YMR291W Cytoplasm, Nucleus Cytoplasm, Nucleus 
YNR047W Cytoplasm Cytoplasm 
YPK1 Cytoplasm Cytoplasm 
YPK2 Cytoplasm, Nucleus Cytoplasm, Nucleus 
YPL141C Cytoplasm Cytoplasm 
YPL150W Cytoplasm (faint) Cytoplasm (faint) 
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3. Synthetic Genetic Analysis of the RAM network During Hyphal 




Candida albicans is the most prevalent fungal pathogen of humans. It lives as a 
commensal in the gastrointestinal and genitourinary tract of humans and is 
normally harmless. However, in certain favorable conditions, such as upon a 
decrease in host immunity or extended antibiotic treatment that eliminates 
competing bacteria, it proliferates and causes local mucosal infections as well as 
serious systemic infections (Mitchell, 1998; Pappas et al., 2004). Systemic 
infections normally occur in immunocompromised patients that have undergone 
bone marrow or organ transplants or in patients undergoing chemotherapy. 
HIV/AIDS patients also almost always develop both local candidial infections of 
the esophagus or the oropharynx as well as invasive candidial infections, though 
the latter are less common (de Repentigny et al. 2004). Invasive candidial 
infections lead to death in approximately 40% of cases, making Candida albicans 
an extremely important pathogen (Wisplinghoff et al., 2004). An additional 
complication is that extended anti-fungal treatment due to the recurring nature of 
the disease has led to resistant strains of Candida (Enoch et al., 2006). This in 
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turn has led to the use of stronger anti-fungals that invariably have undesirable 
side effects. Thus there is an urgent need for newer drugs with more specificity to 
treat these infections.  
Candida exists in multiple morphological forms, the most important being 
yeast, pseudohyphal and hyphal. It is believed that the ability to switch forms is 
tightly linked to its virulence (Mitchell, 1998). This is seen in both in vivo as well 
as ex vivo models of candidiasis where mutant C.albicans strains that could not 
produce hyphae had decreased virulence (Loh et al., 1997; Jayatilake et al., 
2006). It is believed that the yeast form is important for dissemination in the 
bloodstream whereas the pseudohyphal and hyphal forms help in invading 
tissues and destroying macrophages after ingestion, thus evading the host 
immune system (Gow, 2002). An understanding of hyphal development is 
important in the design of drugs to inhibit this process and thus halt disease 
progression. In this context there have been a number of studies to delineate the 
intracellular signaling machinery that leads to hyphal development (reviewed in 
Biswas et al., 2007; Cottier and Mühlschlegel, 2009; Hall et al., 2009).  
A number of signaling pathways that lead to hyphal growth have been 
identified in Candida albicans (Song et al., 2008; Dhillon et al., 2003). One of 
these, the RAM (Regulation of Ace2p and Morphogenesis) network is an 
evolutionary conserved pathway that regulates various processes in eukaryotes 
such as cell separation, daughter cell-specific transcription and polarized growth 
(Nelson et al. 2003; Voth et al., 2005; Walton et al., 2006). In C.albicans this 
pathway is also involved in hyphal development (Song et al., 2008). The RAM 
80 
network is comprised of six genes (Figure 3-1), present in both Saccharomyces 
cerevisiae and C.albicans.  One of these genes, CBK1 has been studied in 
S.cerevisiae and is shown to phosphorylate the transcription factor, Ace2p which 
leads to Ace2p localization to the daughter cells (Mazanka et al., 2008; Sbia et 
al., 2008). Other elements of this network are however not identified, nor is it 
known how the RAM network interacts with the other morphogenetic signaling 
pathways. In S.cerevisiae, a connection between the RAM network and the 
Protein Kinase A (PKA) pathway has been suggested (Schneper et al., 2004). 
The cyclicAMP-dependent PKA pathway is a conserved eukaryotic signaling 
pathway that regulates various processes in the cell, such as cell growth, bud 
site selection and filamentous/hyphal growth (Broach 1991; Pan and Heitman 
1999; Giacometti et al., 2009). Schneper et al. showed that an overexpression of 
one of the catalytic subunits of PKA, namely TPK1, suppressed budding defects 
of a cbk1 null mutant, thus suggesting that these pathways may function in 
parallel. In C.albicans, CBK1 has been shown by at least two groups to be 
required for hyphal development (McNemar et al., 2002; Uhl et al., 2003). The 
Ace2p transcription factor of the RAM network has been shown to play a role in 
hyphal development and regulates a number of metabolic genes under hypoxic 
conditions (Mulhern et al. 2006). 
In this study we examine how the RAM network regulates hyphal 
developmental using large-scale synthetic genetic analysis. Synthetic genetic 
analysis has been used successfully in S.cerevisiae in a number of studies 
(Davierwala et al., 2005; Boone et al., 2007). Synthetic interactions involve a pair 
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of mutations that result in a phenotype not observed in either single mutant; for 
example, the deletion of two non-essential genes may result in cell death.  Such 
interactions can help uncover functions of redundant genes, as researchers may 
screen a specific mutant for second-site mutations that either suppress or 
enhance the original phenotype. Tong et al. (Tong et al., 2001) developed a 
method enabling synthetic genetic analysis on a large scale in S.cerevisiae, 
called the synthetic genetic array (SGA) method. This involved the systematic 
construction of double-mutants by crossing a query mutation to an array of ~4700 
haploid deletion mutants.  Double-mutant progeny were subsequently scored for 
viability.  Any inviable progeny would indicate a synthetic lethal interaction 
between the two deleted genes, thus identifying functional relationships between 
genes. The fact that S.cerevisiae exists as a stable haploid facilitated this kind of 
analysis.  
Synthetic genetic analysis on a large scale has so far not been attempted 
in C.albicans. One of the reasons is the difficulty in generating strains mutant at 
two different loci due to the fact that it lacks a viable haploid stage. To circumvent 
this issue, we have made use of the property of gene haploinsufficiency in this 
large-scale synthetic genetic analysis. Haploinsufficiency describes the situation 
when mutation in one allele of a given gene results in a measurable phenotype. 
A large-scale transposon mediated gene disruption study in C.albicans 
previously made use of haploinsufficiency to identify genes involved in the yeast-
hyphal transition (Uhl et al., 2003). One of the genes identified was CBK1 (Cell 
wall Biosynthesis Kinase), a Ser/Thr kinase of the RAM network. In S.cerevisiae, 
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Haarer et al. studied synthetic genetic interactions of haploinsufficient genes and 
successfully identified over 200 actin-interacting genes that showed defects in 
the actin cytoskeleton (Haarer et al., 2007). This is known as complex 
haploinsufficiency (CHI) where a strain with two heterozygous mutations displays 
a more severe phenotype than either single mutant. This method can be 
successfully used to identify genes with similar function.  In this study, we have 
used CHI in a C.albicans strain heterozygous for the RAM network kinase gene, 
CBK1. We identified 151 genes showing decreased hyphal growth relative to the 
CBK1 heterozygote, including 44 genes that genetically interact with CBK1. Our 
results have also established a possible connection between the RAM and PKA 
pathways in hyphal development, besides identifying 17 putative targets of the 
RAM network transcription factor, Ace2p. 
 
3.2. Materials and Methods 
 
3.2.1. Strains and growth conditions: 
 
CAMM-292 (ura3Δ::imm434/ura3Δ::imm434/cbk1-Δ1::hisG/CBK1) (McNemar 
and Fonzi, 2002) was used as the parental strain for the transposon 
mutagenesis. CAI4 (ura3Δ::imm434/ura3Δ::imm434) and CAMM-29 
(ura3Δ::imm434/ura3Δ::imm434/cbk1-Δ1::hisG-URA3-hisG/CBK1) were used for 
comparison of  hyphal growth phenotypes (McNemar and Fonzi, 2002).  
Standard yeast media was used for growth of strains with slight 
modifications. More specifically, strains for transformation were grown in liquid 
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YPD medium containing 80mg/l uridine at 30°C(Bensen et al., 2005). URA+ 
transformants were grown on standard SC-URA plates at 30°C. Screening of 
insertion mutants was carried out on solid Spider medium at 37°C for 5 days (Uhl 
et al., 2003).  
3.2.2. Transposon Mutagenesis:  
 
C.albicans strain WO-1 pEMBLY23 genomic DNA library (NIH AIDS Research & 
Reference Reagent Program; Slutsky et al., 1987; Baldari et al., 2005) was used 
as the starting material for the transposon mutagenesis. Mutagenesis was 
performed in vitro using the GPS3-Mutagenesis system from NEB, with 80ng of 
DNA library and 20ng of donor plasmid. The donor plasmid was first modified to 
contain the Candida-specific URA3-dpl200 cassette (Wilson et al., 2000) at the 
SpeI restriction site to enable selection of C.albicans transformants. A total of 
nine independent mutagenesis reactions were performed. The transposon-
inserted library plasmids were transformed into DH5α cells and selected on 
LB+Amp+Kan plates. Plasmids were recovered by Maxiprep (Qiagen), digested 
with PvuII to release the genomic DNA fragments and transformed into 
C.albicans strain CAMM-292 using a standard lithium acetate transformation 
protocol (Geitz et al., 1992). Slight modifications of this protocol were used, 
namely heat shock temperature of 44°C for 20 minutes (Walther and Wendland, 
2003) before plating. Each fragment integrates into the genome via homologous 




3.2.3. Screening for hyphal growth phenotypes:  
 
URA+ transformants were grown overnight in liquid SC-URA medium in 96-well 
plates and replica-plated using a hand-pinning tool onto Spider media in 
duplicate. Plates were incubated at 37°C for 5 days. Colonies with altered hyphal 
growth relative to the starting strain CAMM-292 were scored as positive. These 
were retested on Spider plates and incubated as before to confirm the 
phenotype.  
3.2.4. Identification of transposon insertions:  
 
Transposon insertion sites were identified by 3’RACE (rapid amplification of 
cDNA ends) as follows. Total cellular RNA was extracted (Ambion Ribopure) 
from the transposon-inserted strains, reverse transcribed into cDNA using M-
MLV reverse transcriptase (Invitrogen) and a 3’ RACE adapter. A fragment of the 
URA3 marker from each strain was amplified by PCR using primers 
complementary to the 3’RACE adapter and the 3’end of URA3 gene. The PCR 
product contains the transposon insertion site in the genome. PCR products were 
cloned into a TA vector followed by sequencing and BLASTN analysis. Gene 
sequences were compared and identified using the Candida Genome Database 
(www.candidagenome.org). 
3.2.5. Confirmation of synthetic interactions:  
 
CBK1 was re-integrated into each double heterozygote using plasmid pMM4 
(McNemar and Fonzi 2002) which carries the entire CBK1 ORF and its promoter 
region. Since the selectable marker in pMM4 is URA3, similar to the transposon 
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marker used, we had to cure the strain of this marker before reintroducing CBK1. 
To do this, we used the standard 5’FOA (5’ fluoroorotic acid) selection method 
(Boeke et al., 1987). 5’FOA is a compound that is converted to 
fluorodeoxyuridine, a toxic intermediate, by yeast cells containing a wild type 
URA3 gene. Thus only cells that do not possess a wild type URA3 gene are able 
to survive on media containing 5’FOA with uracil added exogenously. The double 
heterozygotes were first grown in liquid YPD with 80mg/l uridine for 48 hours to 
encourage loss of the URA3 marker (Monteoliva et al., 1996). A dilution was then 
plated on Synthetic Complete media containing 80mg/l uridine and 1mg/ml 
5’FOA. Colonies were picked at random and replica plated onto YPD + uridine 
plates and SC-Ura plates. Colonies on YPD + uridine plates that did not grow on 
SC-Ura were scored as positive i.e. they had lost the URA3 marker. These were 
then picked as candidates for transformation of CBK1.  
For the CBK1 transformation, pMM4 was linearized with BsrGI and 
transformed into each transposon-inserted Ura- strain. The resultant CBK1-
integrated transformants were selected on SC-URA. These were then screened 
on Spider medium as earlier and an increase in hyphal growth compared to that 
of the double heterozygote was scored as positive. Integration of CBK1 was 







3.3.1. Construction of double heterozygotes:  
 
We performed transposon mutagenesis across the C.albicans genome in a 
CBK1 heterozygous mutant strain in order to screen for double mutants with a 
hyphal growth defect more severe than the CBK1 heterozygote. Transposon 
mutagenesis is a useful method for large-scale mutagenesis of various 
organisms. It has been used often in S.cerevisiae to perform genome-wide gene 
disruptions in a relatively quick and straightforward method (Burns et al., 1994; 
Ross-McDonald et al. 1999; Kumar et al. 2000; Kumar et al., 2004). In 
C.albicans, two groups have made use of this method independently to generate 
homozygous (Davis et al., 2002; Richard et al., 2005) and heterozygous (Uhl et 
al., 2003) mutants to study various aspects of hyphal development.  
As a resource for large-scale screening, transposon insertion mutants 
offer both advantages and disadvantages.  The advantage of using transposon-
mediated gene disruption is that the mutagenic event is not biased towards 
annotated genes (Ross-McDonald et al. 1999), so uncharacterized open reading 
frames (ORFs) are also disrupted. Transposon insertion mutants can be used to 
generate a greater variety of mutant alleles than can be obtained using a single 
treatment with chemical mutagens or ultraviolet radiation (Kumar and Snyder, 
2001). Furthermore, both coding and non-coding regions may be disrupted 
depending upon the site of insertion; so, the phenotypic consequences of 
disrupted regulatory regions, like promoters and terminators, can also be studied.  
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A limitation of this approach is that the transposon insertion collection is 
not comprehensive; transposition is a random process, making it difficult to 
obtain an insertion affecting each yeast gene. In addition, the transposon might 
insert into a gene in such a way that it does not disrupt gene function. Finally, the 
specific collection of mutants that is obtained is dependent on the specific 
genomic library that is used as the receptor plasmids. In spite of this, transposon-
mediated gene disruption remains an extremely useful way to generate large 
collections of mutants and is one of the few widely available methods applicable 
for large-scale mutagenesis in C. albicans.   
In our study, we made use of a transposon derived from the Tn7 bacterial 
transposon (Biery et al., 2000), and modified it to contain a C.albicans-specific 
URA3 selectable marker. We used this modified transposon in an in vitro 
mutagenesis reaction with a C.albicans genomic DNA library derived from the 
WO-1 strain (NIH AIDS Research & Reference Reagent Program; Slutsky et al., 
1987; Baldari et al., 2005). After amplification of the transposon-inserted plasmid 
library in Escherichia coli, the plasmids were transformed into the CBK1 
heterozygote to generate a total of 6,528 transposon-inserted strains that were 
heterozygous at CBK1 and a second locus (Figure 3-2).  
3.3.2. Identification of genes displaying complex haploinsufficiency 
with CBK1: 
To identify genes that synthetically interact with CBK1 to produce a hyphal 
growth defect, we performed a phenotypic screen. We first considered the media 
to use in the complex haploinsufficiency screen to ensure it was sensitive enough 
88 
to detect small changes in hyphal growth that would be brought about by 
disrupting a single allele. Two previous studies had independently identified 
CBK1 as a gene which when disrupted, showed a hyphal growth defect on 
certain media, namely, solid Spider medium (McNemar and Fonzi, 2002; Uhl et 
al., 2003). The Fonzi group isolated the CBK1 gene and subsequently tested 
both heterozygous and homozygous mutants for hyphal growth defects on 
various media, including Spider. Uhl and colleagues tested various media and 
concluded that certain media such as Spider, was sensitive enough to detect 
slight differences in hyphal growth phenotypes such as might occur with 
haploinsufficiency. We tested a couple of different conditions, namely Media 199 
and Spider media, both in liquid and on plates and at two different temperatures, 
30°C and 37°C as reports in the literature cite both as valid hyphal growth 
temperatures (Antley and Hazen, 1988; McNemar and Fonzi, 2002).  
We initially compared hyphal growth of the wild type CAI-4 strain, the 
CBK1 heterozygote and the CBK1 homozygote and decided that the condition 
that produced the best results, i.e. allowed us to distinguish phenotypes better 
was solid Spider medium at 37°C (Figure 3-3). We tested our entire collection of 
6,528 insertion mutants for alterations in hyphal growth by spotting cultures on 
96-well format plates in duplicate and incubating them for 5 days. Hyphal growth 
phenotypes were compared to the original CBK1 heterozygous strain. A 
decrease in hyphal growth, namely reduction or absence of peripheral hyphae or 
wrinkling at the center was scored as positive. A representative plate obtained 
from the screen is shown in Figure 3-4. After retesting these strains in duplicate 
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as earlier, 441 out of 1,810 showed consistent hyphal growth defects and were 
considered as our final set of putative CBK1 interactors. 
The genes disrupted by the transposon insertions were identified using the 
3’RACE (Rapid Amplification of cDNA Ends) as described in the methods 
section. Identification of 151 insertion mutants revealed 53 unique genes that 
potentially interact with CBK1/RAM network during hyphal growth. The full list of 
genes is shown in Table 3.1. Of these, 16 genes were found to be regulated by 
the RAM network and 9 genes were regulated by the PKA pathway. We also 
identified 22 new genes involved in hyphal development, besides confirming 24 
previously characterized hyphal growth genes. 
An important issue in the study of hyphal growth phenotypes in C.albicans 
concerns expression of the URA3 gene. URA3 is a conserved gene and encodes 
for orotidine-5'-phosphate decarboxylase, a pyrimidine biosynthesis enzyme. 
Though it is a popular selection marker, being one of the first few markers 
available in C.albicans, some studies have shown that differences in expression 
of this gene can lead to hyphal growth defects (Lay et al., 1998; Bain et al., 
2001). This defect can be reversed by addition of uridine to the growth medium 
(Sundstrom et al., 2002; Uhl et al., 2003). To confirm that the hyphal growth 
phenotypes observed were due to the transposon insertions and not URA3-
position related effects, we retested the identified insertion mutants on Spider 
medium containing uridine. All the mutants tested showed hyphal growth defects, 
just as on the original Spider plates (data not shown), confirming that URA3 
expression was not responsible for the phenotypes. 
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3.3.3. Confirmation of true synthetic interactions with CBK1:  
A critical issue we had to contend with in our complex haploinsufficiency screen 
was to distinguish hyphal growth defects occurring due to genetic interactions 
with CBK1 as opposed to defects occurring due to the second-site mutations 
alone. Since our aim was to identify genes that genetically interact with CBK1 
during hyphal growth, it was important to distinguish phenotypes resulting from 
such genetic interactions versus hyphal growth defects occurring due to the 
transposon-mediated disruption of genes.  
To confirm that the genes we identified were true synthetic interactors of 
CBK1/RAM network, we performed a complementation test. CBK1 on a plasmid 
was re-introduced by transformation into each double heterozygous strains as 
described in Methods. Transformants were screened on Spider medium for 5 
days at 37°C as in the previous screen. Hyphal growth phenotypes were 
compared to the original transposon-inserted double heterozygotes and those 
that showed less severe hyphal growth defects were considered as true synthetic 
interactors of CBK1. Out of the 53 genes, only seven (ALS4, CCT7, CYS3, 
HGT6, RPS12, SSD1 and 19.334) showed a severe hyphal growth defect after 
CBK1-reintroduction indicating that the transposon insertion itself was 
responsible for the phenotype. The majority showed wild type phenotype with 





3.3.4. RAM network genes and putative Ace2p targets identified:  
Three classes of interacting genes are likely to be identified using a complex 
haploinsufficiency screen such as this. One class of genes is those genes that 
function in the same pathway as CBK1 (the RAM pathway) if, for example, partial 
loss of activity in two components of the pathway leads to an additive effect. This 
would lead to a more severe phenotype compared to loss of just one component, 
namely, CBK1. Another class of genes is genes that belong to a parallel pathway 
leading to the same outcome (i.e. hyphal growth).  A third class of genes would 
be genes that are defective in the general fitness of the strain and so show 
hyphal growth defects – these would likely be identified as slow growing strains.  
We identified sixteen genes from our screen that had been previously 
characterized as RAM network-regulated genes by the fact that they have altered 
expression in an ace2Δ mutant (Mulhern et al., 2006). Our CHI screen thus 
successfully identified genes with a direct mechanistic relationship to the query 
mutant, the CBK1 heterozygote. In the same previous study of the comparative 
transcriptional profiles of a Candida albicans ace2Δ mutant and a wild type 
strain, Mulhern et al. defined a candidate consensus binding site for Ace2p, 
namely AACCAGC. We analyzed the promoter regions of our list of 53 identified 
genes and found this binding site in 17 of the genes; the sequences differed by 
no more than one base at positions other than the core sequence, xxCCAxC 
(Table 2). Out of these, 12 had not been previously identified as potential Ace2p 
targets. Further work will need to be done to confirm that these are true Ace2p 
targets. 
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3.3.5. The RAM network and PKA pathway function in parallel during 
hyphal growth: 
 We closely examined the set of 53 identified genes, using the Candida Genome 
Database as well as the existing literature and identified nine genes (ADE4, 
ALS4, HGT6, HGT7, MAF1, MP65, UCF1, YKE2 and 19.3644) that were 
regulated by the cAMP-dependent PKA pathway (Bahn et al., 2007). No genes 
regulated by other hyphal growth pathways, such as RIM101, HOG1 or the 
CPH1 MAPK pathway, were found amongst our list. The RAM and PKA 
pathways both regulate genes involved in metabolism, cell wall and ergosterol 
biosynthesis, new bud formation, polarized growth and hyphal development. With 
this in mind, we compared two recent studies done in C.albicans of the 
transcriptomes of mutants of both pathways; an ace2Δ mutant (Mulhern et al., 
2006) and a cap1Δ (adenylate cyclase-related protein) mutant (Bahn et al., 
2007). This comparison showed that these pathways regulate a set of 11 genes 
common to both pathways, besides regulating other pathway-specific genes.  
The presence of a substantial number of PKA-regulated genes in our 
synthetic genetic screen as well as the transcriptional data from the literature 
suggests a possible link between the PKA pathway and CBK1/RAM network in 
C.albicans. In S.cerevisiae, as mentioned earlier, it has been suggested that the 
PKA and RAM pathway function in parallel in bud site selection (Schneper et al.,  
2004). The same study identified the small GTPase RHO1 as a possible 
common target of both pathways. CBK1 seems to negatively regulate RHO1 
since null mutations in GTPase activating proteins (GAPs) in a cbk1Δ 
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background cause a synthetic slow growth phenotype.  In our study, we identified 
an uncharacterized GAP (RGD3) that is homologous to a RhoGAP (RGD2) in S. 
cerevisiae.  This evidence, along with the fact that about 17 % of our set of 
identified genes consists of PKA pathway regulated genes, suggests that the 
PKA pathway and the RAM network function in parallel in C. albicans to regulate 




Candida albicans is undoubtedly an important human pathogen and the center of 
a host of studies that aim to understand its pathogenesis. It causes both local 
mucosal infections in healthy individuals as well as life-threatening systemic 
candidial infections in immunocompromised patients. These infections are 
typically treated with azole antifungals such as fluconozale or itraconazole, 
however, as this disease tends to recur, azole-resistant non-albicans Candida 
species emerge (Rex et al., 1995). Further treatment involves the use of 
pharmacological agents that have more side effects or that need to be 
administered intravenously (Enoch et al., 2006). Thus there is a dire need to 
design new drugs with more specificity and fewer undesirable side effects. As its 
ability to cause disease is closely linked to its ability to transition between 
morphological yeast and hyphal forms, morphogenesis in C.albicans has been 
the focus of many studies. By understanding components involved in this 
process, new drug targets can be identified and subsequently used in 
pharmacological studies. The fact that Candida exists as a diploid without a 
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viable haploid stage has somewhat hampered studies of gene function, resulting 
in less than optimal studies in this organism. Though single gene / pathway 
studies are extremely important, large-scale genomic studies allow faster data 
collection and should speed up the process of drug discovery.  
With the sequencing of the C.albicans genome in 2004, many groups 
have made use of this data for large-scale studies such as genome-wide 
transcriptional analysis (Nantel et al., 2002; Mulhern et al., 2006; Bahn et al., 
2007), transposon-mediated gene disruptions (Davis et al., 2002; Uhl et al., 
2003;  Nobile and Mitchell, 2006), and essential gene identification using gene 
deletion and promoter-replacement (Roemer et al., 2003). In this study we 
performed the first ever large-scale synthetic genetic screen in Candida albicans. 
This study has not been attempted so far in Candida though there are numerous 
examples of it being used successfully in S.cerevisiae to identify genes and 
networks involved in cellular processes (Davierwala et al., 2005; Boone et al., 
2007). We used transposons to disrupt genes across the genome in a strain 
heterozygous for a RAM network kinase, CBK1. Using complex 
haploinsufficiency (CHI), we examined the mechanism by which the RAM 
network regulates hyphal development and showed that this method can be 
successfully used to identify genes and networks involved in hyphal growth in 
C.albicans.  
We uncovered a potential link between the RAM network and the cAMP-
dependent PKA pathway and believe that these pathways function in parallel to 
regulate hyphal development in this species. In addition, we identified several 
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potential targets of the Ace2p transcription factor of the RAM network, and upon 
confirmation, will show that a CHI screen can identify genes with a mechanistic 
relationship to the query mutation. We also identified a considerable number of 
new genes involved in hyphal development, including several uncharacterized 
genes. Our study has confirmed previously characterized hyphal growth genes 
as well. We have shown how CHI is useful not only to identify genes in the same 
pathway as the starting mutant, but also identify genes in other networks that 
interact with this pathway and to uncover genes with redundant functions. Using 
the property of haploinsufficiency eliminates the need to perform the laborious 
process of disrupting both alleles; this facilitates studies in an asexual diploid 
such as Candida. The transposon-based gene disruption method is useful for 
large-scale mutagenesis in Candida, as it is relatively quick and not as 
cumbersome as PCR-mediated gene deletions. 
 Transposon-mediated gene disruption methods are not without 
limitations. As mentioned before, transposons insert randomly into the genome 
but there is a certain level of bias since they insert more frequently into some 
areas of the genome compared to others. Also, it is difficult to determine the 
completeness of the starting genomic DNA library. In spite of these limitations, 
our screen revealed far more relevant results than what typically can be achieved 
from a large-scale screen. Many of the identified genes are regulated by the 
RAM network which includes cell wall genes like RBT5, metabolic genes, ADH1, 
LEU42 and MET2 and genes involved in glucose response – HGT6, PGK1, 
ENO1. Seventeen potential Ace2p targets were identified, including twelve new 
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target genes. In addition, a substantial number were genes regulated by the PKA 
pathway, another pathway involved in hyphal developmental in Candida. This, 
along with other evidence mentioned earlier, supports the idea that the RAM and 
PKA pathways function in parallel to regulate hyphal growth. The PKA pathway-
regulated genes include glucose transporters HGT6 and HGT7, and a number of 
known hyphal-growth related genes such as the agglutinin family gene ALS4, 
cytoskeleton modulator YKE2, cell surface protein MP65 and PKA pathway-
specific genes, UCF1 and the uncharacterized 19.3644. Besides these, 22 new 
hyphal-growth genes involved in various cell processes have been identified 
such as stress responsive genes HSP60 and HSP30; cytoskeletal genes ACT1 
and CCT7, transport genes CCC1, ribosomal genes RPS1, RPS12 and RPL15A 
and a number of uncharacterized genes. 
Morphogenesis is a complex process as evidenced by the fact that there 
are at least six signaling pathways identified in Candida (Brown and Gow, 1999).  
Though these are triggered by a host of inducing agents, such as low nitrogen, 
carbon source, high phosphate and physiological conditions such as serum and 
high temperatures, there are certain inducing agents specific to certain pathways. 
For example, the RIM101 pathway is activated in response to alkaline conditions 
(Davis et al., 2000), the HOG1 pathway responds to oxidative stress (Román et 
al., 2005). Studies of mutants of the CPH1 MAPK pathway have shown that 
disruption of certain MAPK cascade genes leads to hyphal growth defects when 
the inducer is Spider medium (that uses mannitol as a carbon source) but 
continue to form hyphae when serum is used as the inducing agent (Köhler and 
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Fink, 1996). In this context, it would be interesting to perform similar CHI screens 
using different inducing conditions and compare the resulting gene sets. This 
would help delineate the specific triggers and possibly help uncover the sensors 
that lead to activation of these pathways. Another interesting possibility is to 
repeat the CHI screen with different query mutants in different pathways. Though 
this would involve a substantial amount of work, it would help uncover the 
connections between networks in Candida morphogenesis and ultimately lead to 
construction of a genome-wide network map of this process. Information gained 
from this would undoubtedly aid in uncovering important pharmacological targets, 
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Figure 3-1 Simplified schematic of the Regulation of Ace2p and 
Morphogenesis (RAM) pathway. Interaction of the network proteins leads to 
activation of the kinase Cbk1p which phosphorylates the transcription factor 
Ace2p. This leads to activation of target genes involved in diverse cellular 
processes like cell separation, polarized growth, metabolism and hyphal growth. 
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Fig. 2. Simplified Schematic of the Regulation of Ace2p and
Morphogenesis (RAM) pathway.Interaction of the network
proteins leads to activation of the kinase Cbk1p which






Figure 3-2 Schematic overview of the construction of C. albicans Tn7 
transposon library and insertional mutagenesis of cbk1Δ /CBK1. The Tn7-
transposon donor plasmid is modified to contain the URA3dpl200 cassette by 
PCR amplification of the cassette using primers with SpeI sites in the flanking 
sequences and subsequent ligation to SpeI-digested donor plasmid. The C. 
albicans genomic DNA library is subjected to in vitro mutagenesis. Tn7-
mutagenized inserts contained in the resulting library are released from the 
plasmid by digestion with PvuII, which cuts at two sites flanking the position 
where the C. albicans genomic DNA inserts were cloned into the original donor 
plasmid. The resulting linear DNA was transformed into the ura-, cbk1Δ/CBK1 
strain. The transposon cassettes are directed by the flanking sequences of C. 
albicans DNA and insert into the chromosomes by homologous recombination. 





Figure 3-3 Comparison of colony and cellular morphology of wild type 
CAI4, heterozygous mutant cbk1Δ /CBK1 and null mutant cbk1Δ / cbk1Δ 
strains. (A) Strains were spotted on Spider + uridine medium and incubated at 
37°C for 5 days to induce hyphal growth. (B) Strains were grown overnight in 
YPD+ uridine at 30°C and then inoculated into liquid Spider + uridine at 37°C for 
6 hours to induce hyphal growth. Strains were (C) spotted on YPD + uridine and 










Figure 3-4 Screening of Tn7 transposon-inserted transformants on Spider 
plates for hyphal growth phenotypes. Transformants were grown overnight in 
SC-Ura and then spotted in 96-well format using a hand pinning tool on Spider 
medium. Plates were incubated at 37°C for 5 days. Colonies showing reduced or 
null hyphae as compared to cbk1Δ/CBK1 were scored as positive (example of 
such colonies shown by the pointed arrow). These were retested on Spider 




Figure 3-5 Secondary phenotypic screen to identify double mutants 
displaying complex haploinsufficiency. CBK1 on integrative plasmid pMM4 
was re-transformed into the double heterozygous mutants to generate single 
heterozygous strains wild type for CBK1. These transformants were grown 
overnight in SC-Ura and then spotted on Spider medium. Plates were incubated 
at 37°C for 5 days. Hyphal growth phenotypes of the single heterozygous Tn7-
insertion mutants were compared to the original double heterozygous mutants. 
(A) Group I: Single heterozygous strains showing reduced hyphal growth defects 
as compared to the double heterozygous mutant. Phenotype of the UCF1 mutant 
is shown and is a representative image of all strains within this group. (B) Group 
II: Single heterozygous strains with no reduction in hyphal growth defects as 
compared to the double heterozygous mutant. Phenotype of the HGT6 mutant is 














ALS4    HGT6      19.334
CCT7    RPS12
CYS3   SSD1
ACT1    ENO1     MAF1    PPA1     SFL1    VPS13     19.6596
ADE4    FAA4      MET2    RBT5     SMI1    YKE2       19.263.1
ADH1    GPD2     MP65    RGD3    SNZ1    19.1152  
AIM38   HGT7     NSP1    RNR22   SSS1    19.133
ATP3     HSP60   OCH1    RPB5     TRM1  19.2048
CCC1    KER1     PGK1    RPL15A  TRX1   19.3644









Table 3-1 List of identified genes from the screen. A brief description of the 
genes derived from the Candida Genome Database (candidagenome.org) is 
presented here. The last column classifies the genes into the following groups: 
(1) RAM pathway-regulated; (2) PKA pathway-regulated; (3) Genes previously 
linked to hyphal growth/biofilm formation and (4) Genes not previously linked to 
hyphal growth/biofilm formation. 
      
Gene Description Classification 
ACT1 Actin; Regulated by growth phase and starvation 4 
ADE4 Purine biosynthesis pathway? 1, 2 
ADH1 Alchol dehtdrogenase 1, 3 
AIM38 Predicted membrane protein. Mitochondrial? 3 
ALS4 Adhesion and WT germ tube induction 2, 3 
ATP3 Macrophage/pseudohypal induced. ATP synthesis? 3 
CCC1 Putative Fe2+/Mn2+ transporter 4 
CCT7 Cytoskeleton organization and biogenesis;protein folding 4 
COX8 Cytochrome oxidase activity? 4 
CYS3 Sulfur amino acid biosynthesis? Biofilm-upregulated 1 
ENO1 Enzyme of glycolysis and gluconeogenesis; Biofilm regulated 1, 3 
FAA4 Acyl-CoA synthase? 1 
GPD2 Similar to glycerol 3-P dehydrogenase; pseudohyphal growth 1, 3 
HGT6 Putative glucose transporter 1, 2 
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Gene Description Classification 
HGT7 Putative glucose transporter 2, 3 
HSP30 Similar to heat shock protein; fluconazole-downregulated 4 
HSP60 Mitochondrial heat shock protein 4 
KER1 Alkaline-induced PM protein; affects cell aggregation 1, 3 
KRE1  1,6-beta-D-glucan biosynthesis 4 
LEU42 Leucine synthesis; upregulatd by human whole blood 1, 3 
MAF1 Nucleocytoplasmic transport; synthesis of RNA Pol II 2, 3 
MET2 Methionine  synthesis;  macrophage/pseudohyphal repressed 1, 3 
MP65 Cell surface mannoprotein; induced upon germ tube formation 2, 3 
NSP1 Essential component of nuclear pore complex? 4 
OCH1 Alpha-1,6-mannosyltransferase; required for virulence 3 
PGK1 Phosphoglycerate kinase; Biofilm-induced 1, 3 
POL5 Induced upon biofilm formation 3 
PPA1 Vacuolar ATPase? 4 
RBT5  Cell wall protein involved in hemoglobin utilization 1, 3 
RGD3 Rho GTPase activating protein?  1 





RNR22 Ribonucleoside diphosphate reductase 1 
RPL15A Protein component of large ribosomal subunit 4 
RPS1 Ribosomal protein? Transcription induced during active growth 4 
RPS12 Acidic ribosomal protein S12 4 
SFL1 Negative regulation of flocculence and filamentous growth 3 
SMI1 Decreased mRNA abundance in cyr1 null hyphal cells 1, 3 
SNZ1 Stationary-phase protein; induced on yeast-hyphal switch 1, 3 
SSD1 Role in resistance to host antimicrobial peptides; virulence role 3 
SSS1 Subunit of Sec61p translocation complex? 4 
TRM1 tRNA methyltransferase; induced upon adherence to polysterene 3 
TRX1 Similar to thioredoxin; Biofilm induced 3 
UCF1 Upregulated by cAMP in filamentous growth 2, 3 
VPS13 Vacuolar protein sorting? 4 
YKE2 Cytoskeleton modulator? Induced upon yeast-hyphal switch 2, 3 
19.1152 Induced in core stress response 4 
19.133 Induced by nitric oxide 4 





19.2048 Transcription is positively regulated by Sfu1p (iron) 4 
19.263.1 Uncharacterized 4 
19.3644 Greater mRNA abundance in cyr1 homozygous null mutant 2, 3 
19.384 Uncharacterized 4 
19.6596 Transcriptionally regulated by Tac1p(drug), Mnl1p(stress) 4 




Table 1-1 List of genes with consensus Ace2p binding sites in promoter 
regions.  Genes listed in bold font have decreased expression in ace2Δmutants 
by microarray analysis.  Small case letter indicates position where identified 
sequence differs from the consensus sequence. All listed sequences differ by no 
more than one base at positions other than the core xxCCAxC. Position denotes 
the position of putative Ace2p binding site relative to the ATG start codon for the 
indicated ORF.  
 
 Gene Ace2 site    (aaCCAgC) Position 
 
ADH1 AgCCAGC -481 
 ENO1 AACCAcC -195 
 COX8 AACCAaC -448 
 HGT6 AACCAaC -146 
 HGT7 AACCAcC -141 
 HSP60 AACCAaC -318 
 MAF1 AACCAaC -279 
 NSP1 AtCCAGC -200 
 POL5 AACCAaC -57 
 RGD3 AgCCAGC -175 
 RPB5 AACCAaC -225 
 SFL1 AACCAtC -885 
 SNZ1 AACCAaC -431, -169 
 TRM1 AACCAcC -741 
 TRX1 AACCAaC -211 
 UCF1 AACCAGC -926 
 19.384 AACCAaC -89 
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1. Conclusions and Future Directions 
 
 
The budding yeast Saccharomyces cerevisiae is well recognized as a preferred 
eukaryote for the development of genomic technologies and approaches. Yeast 
has proven to be useful in gaining knowledge about various cell processes in 
eukaryotes, such as the cell cycle, DNA replication and repair, protein translation 
and post-translational modifications (Melese and Hieter, 2002). A sizeable 
complement of genomic resources has been developed in yeast, and this 
genomic foundation is now informing a wide variety of disciplines. In my thesis, I 
make use of genomics to study a particular growth process, namely filamentous 
growth in budding yeast. Chapter 1 introduces baker’s yeast as a model for 
eukaryotic cell biology and genetics and illustrates genomic studies that have 
been carried out by various groups. In this chapter, I also present the human 
fungal pathogen, Candida albicans and discuss work on filamentous (hyphal) 
growth that has been done by the Candida community. 
Filamentous growth, as mentioned earlier is a developmental process that 
certain strains of yeast undergo. In response to certain stress conditions such as 
nitrogen limitation or the presence of short chain alcohols like butanol and 
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ethanol, the yeast cell changes form from the oval, budded form to the 
filamentous form, which consists of chains of elongated cells (Gimeno et al. 
1992; Madhani and Fink 1998; Lorenz et al., 2000). There have been numerous 
studies of this important process over the years, since it appears strikingly similar 
to the hyphal/filamentous growth of fungal pathogens. Fungal pathogens such as 
Candida albicans switch form from budded to filamentous (hyphal) like 
S.cerevisiae (Sudbery et al., 2004).  It has been suggested that there is a link 
between the ability of fungal pathogens to undergo hyphal growth and to cause 
disease. The switch between growth forms appears to be essential for virulence. 
This was first discovered in a Candida mutant that was defective in hyphal 
formation and was subsequently avirulent in a mouse model (Lo et al., 1997). 
The signaling pathways leading to filamentous/hyphal growth share several 
components; in particular there is a strong degree of gene conservation between 
C. albicans and S. cerevisiae. 
Studies of filamentous growth in budding yeast have been done in an 
attempt to delineate the signaling pathways, their sensors, the downstream 
targets, and the mechanisms by which these pathways interconnect with other 
related cellular processes (e.g., cell cycle progression, bud site selection, etc.). 
There have been studies of single genes/pathways as well as genomic studies 
making use of tools and techniques such as transposon mutagenesis, PCR-
mediated gene deletions, microarrays, and mass spectrometry. Subcellular 
localization of proteins is one method of gene regulation that has not been 
studied in filamentous yeast on a large scale previously. In Chapter 2, I describe 
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a method of localizing the 125 protein kinases during filamentous growth. We 
identified six kinases that change localization under filamentous growth-inducing 
conditions. Further, we show how these kinases form part of an interdependent, 
localization-based regulatory network. We also identified a new filamentous 
growth gene, KSP1, whose nuclear translocation is required for filamentous 
growth. Thus, the localization of Ksp1p and the other kinases identified here is 
tightly controlled during filamentous growth, representing an overlooked 
regulatory component of this stress response.  
 As a follow up to this study, it would be informative to carry out a 
localization study of all the yeast transcription factors to see how many show 
differential localization during filamentous growth. The data from this study would 
no doubt help in forming a better picture of the network of regulated protein 
localization during this process. The identification of KSP1 as a new filamentous 
growth gene was an interesting outcome from this study - further experiments to 
investigate the role of this gene in filamentous growth are expected to be highly 
informative. 
It would be interesting to study further the mechanism by which these 
kinases translocate into the nucleus; only KSP1 contains a putative nuclear 
localization signal (NLS) (as deduced from the program PSORTII). Previous 
studies have shown that Bcy1p translocates from the cytoplasm to the nucleus 
with an interacting protein, Zds1p during temperature stress in the S288C strain 
of budding yeast (Griffioen et al., 2001). Accordingly, a study can be done to see 
if these six kinases are transported into the nucleus with interacting proteins 
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during filamentous growth. In yeast, cargo molecules are escorted to and from 
the nucleus by carrier proteins called karyopherins, of which 14 have been 
identified (Lusk et al., 2002). A protein-protein interaction study using yeast two-
hybrid or co-immunoprecipitation can be done to see if any of these carrier 
proteins interact with and hence, might be responsible for transport of these 
kinases. Alternatively, individually deleting each karyopherin and looking for a 
disruption in kinase nuclear translocation during filamentous growth would 
suggest that particular karyopherin is likely responsible for nuclear transport.  
 Another possible study could be to understand the timing and specificity of 
kinase phosphorylation during filamentous growth.  Do the kinases translocate to 
the nucleus post-phosphorylation, and which kinases are responsible for 
phosphorylation? Finally, to help with identifying components and understanding 
the process of filamentous growth better, it would be useful to try and identify the 
targets of these kinases. These findings could then be applied to hyphal growth 
processes in fungal pathogens, taking us a step closer to understanding 
corresponding cellular process in these organisms. 
Chapter 3 describes a genome-wide synthetic genetic screen in the 
human fungal pathogen Candida albicans in an attempt to identify elements 
involved in hyphal growth. A complex haploinsufficiency screen was carried out 
in a strain heterozygous for the RAM network kinase, CBK1 to identify genes that 
genetically interact with the CBK1/RAM network. Genes were disrupted 
throughout the genome by making use of transposons that randomly insert into 
the genome. This generated double heterozygous strains that were disrupted at 
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the CBK1 locus as well as a second, random locus. Screening these strains for 
defects in hyphal growth led to the identification of 151 strains with decreased 
hyphal growth as compared to the original heterozygote, cbk1Δ/CBK1.  This set 
consists of genes disrupted at 53 unique loci, out of which many are regulated by 
the RAM network, bringing out the high relevance of this study.  
We also identified 17 putative targets of the Ace2p transcription factor of 
the RAM network. These targets were identified on the basis of an identified 
consensus sequence (aaCCAgC) in the promoter region of these genes (Mulhern 
et al., 2006). Of these 17 genes, 12 have not been identified before. To 
determine if these putative target genes are regulated by Ace2p, expression of 
these genes can be compared in the wild type strain, ace2Δ/ace2Δ and 
cbk1Δ/cbk1Δ mutants using quantitative RT-PCR. If a gene showed decreased 
expression in the mutants compared to the wild type strain, it would likely mean it 
is Ace2p- or Cbk1p-regulated. A further study could be done to check if Ace2p 
binds to the promoter regions of these genes. Biochemical tests such as a gel 
mobility shift assay or chromatin immunoprecipitation could be carried out to 
confirm Ace2p binding to the consensus binding site. 
In this study, nine genes regulated by the PKA pathway were also 
identified, and along with other evidence mentioned earlier, led to the hypothesis 
that the PKA and RAM pathway function in parallel during hyphal growth. One 
way in which this hypothesis could be tested is to use quantitative RT-PCR to 
determine if the expression of these nine genes is increased in cbk1Δ or ace2Δ 
mutants as a compensatory effect. Further, a known inhibitor of the PKA pathway 
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(Cloutier et al., 2003) could be added to the cells to see if this increased 
expression is now blocked.  Another study could be done to determine whether 
defects in hyphal growth in cbk1Δ or ace2Δ mutants are exacerbated by PKA 
pathway-inhibitors or suppressed by PKA pathway-activating chemicals 
(Wolyniak and Sundstrom, 2007). 
Besides confirming 24 genes previously known to play a role in hyphal 
development, this study also identified 22 new hyphal growth genes, including 
several uncharacterized genes. Further experiments could be done to 
characterize the role of these genes in hyphal growth that would add to the 
current information on hyphal development and, in turn, pathogenesis of this 
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